JP7650031B2 - Product provision processing device - Google Patents

Description

The present invention relates to a product provision processing device that prevents the wrong product from being provided.

In recent years, vending machines have come to offer a wider variety of products, improving user convenience.

In addition, depending on the product stored in the vending machine (e.g. medicine, alcohol, tobacco, etc.), the product cannot be dispensed to the user until approval and confirmation from the sales manager, etc. are received.

For example, when providing medicines as products from a vending machine, a sales system and method are known in which a pre-installed vending machine (medicine supply device, vending machine) is used to interview a pharmacist via a video conference system or the like, and when the customer decides to purchase the medicine recommended by the pharmacist during the interview, the medicine is provided from the vending machine according to the pharmacist's operation and instructions (see, for example, Patent Document 1 and Patent Document 2).

JP 2013-109414 A JP 2003-114932 A

However, sometimes after a user selects a product, the wrong product is provided by the product provision processing device. This is believed to be often caused by human error, where the replenisher who replenishes the product in the product provision processing device replenishes the wrong product in the designated storage area.

In particular, when pharmaceuticals are provided as products from product provision processing equipment, providing the wrong pharmaceutical can result in health damage from taking the wrong pharmaceutical. Furthermore, some pharmaceuticals have similar trade names, and some pharmaceuticals have the same trade name for the major category but different trade names for the minor category (e.g., ABC 1.0, ABC 2.0, ABC Premium, etc.). For this reason, when pharmaceuticals are provided as products from product provision processing equipment, preventing human error by replenishing personnel and preventing the wrong pharmaceuticals from being provided from the product provision processing equipment is an important issue in preventing health damage.

The present invention aims to solve the above problem and provide a product provision processing device that prevents the wrong product from being provided.

In order to solve the above problems, the present invention provides a product provision processing device having a storage unit for storing products, which, when a product is selected by a user's operation, provides the product from the storage unit in which the selected product is stored, comprising: authentication means for determining whether the product selected by the user is an approved product approved by a person in charge of providing products; product provision means for providing the product from the storage unit on condition that the product selected by the user is determined to be an approved product by the authentication means; incorrect product determination means for determining whether the product to be provided is a correct product stored in the storage unit or an incorrect product; product provision stopping means for stopping the provision of the product from the storage unit; an internal camera for photographing the product stored in the storage unit; and an image display unit for displaying the image ,
The incorrect product determination means, after a replenishment operation of replenishing products in the storage section is performed by a replenisher, photographs the storage section with the internal camera, performs a first pattern matching between the photographed replenishment product image and a sample replenishment product image when a correct product is stored, and determines whether an incorrect product is stored;
The image display unit displays the photographed replenishment product image and the sample replenishment product image in addition to the determination result by the first pattern matching,
The product supply stopping means stops supply of the product from the storage unit in which the erroneous product is stored when the erroneous product determination means determines that the erroneous product is an erroneous product.

Preferably, the product provision processing device according to the present invention is provided with an internal camera that photographs the product stored in the storage unit, and the incorrect product determination means, when in operation and capable of providing products, photographs the product to be provided stored in the storage unit with the internal camera, performs a first pattern matching between the photographed image of the provided product and a sample product image of the correct product, and determines whether the product to be provided is an incorrect product.

Preferably, the product supply processing device according to the present invention includes a confirmation operation receiving unit that receives a confirmation operation by the replenisher to confirm that the photographed replenishment product image corresponds to the sample replenishment product image, and when the confirmation operation receiving unit receives the confirmation operation, the product supply stopping means desirably permits the supply of the product by determining that the replenisher's replenishment work has been completed.

Preferably, the product provision processing device according to the present invention includes an external camera that photographs a user, a user identification means that identifies the user based on an image of the user photographed by the external camera, an ingredient information extraction means that extracts ingredient information about the selected drug if the product selected by the user is a drug, and an abuse prevention determination means that determines whether or not a predetermined number of drugs containing the first ingredient information extracted by the ingredient information extraction means have been provided within a predetermined period of time based on history information of previously provided drugs associated with the user identified by the user identification means, and it is preferable that the product provision suspension means suspends the provision of the product when it is determined by the abuse prevention determination means that a predetermined number of drugs containing specific ingredient information have been provided within a predetermined period of time.

Preferably, the product provision processing device according to the present invention includes an image display unit that displays an image, and a contraindication prevention determination means that determines whether a drug containing a first contraindicated ingredient or a second contraindicated ingredient associated with the second ingredient information extracted by the ingredient information extraction means has been provided during a specific period based on historical information of previously provided drugs associated with the user identified by the user identification means, and the image display unit displays a warning when the contraindication prevention determination means determines that a drug containing a first contraindicated ingredient or a second contraindicated ingredient has been provided during a specific period, and the product provision suspension means preferably suspends the provision of the product when the contraindication prevention determination means determines that a drug containing a first contraindicated ingredient has been provided during a specific period.

The present invention makes it possible to prevent the wrong product from being provided.

FIG. 2 is an example of a perspective view of the product providing and processing device according to the first embodiment of the present invention when a door is closed. FIG. 2 is an example of a perspective view of the product providing and processing device according to the first embodiment when a door is open. FIG. 2 is a schematic diagram showing an example of a side view of the product providing processing device according to the first embodiment; 1 is a block diagram illustrating an example of a configuration of a product providing system according to a first embodiment. 1 is a sequence diagram illustrating an example of a process transition when a reservation is accepted in the product provision system according to the first embodiment. 1 is a sequence diagram illustrating an example of a process transition during reservation receipt in the product provision system according to the first embodiment. 5 is an example of a flowchart showing a main control process of the product providing processing device according to the first embodiment. 10 is an example of a flowchart showing a product replenishment confirmation process of the product providing processing device according to the first embodiment. 13 is an example of a flowchart showing a process for preventing health damage caused by OTC drugs by the product provision processing device according to the first embodiment. 10 is a flowchart illustrating a product provision process of the product provision processing device according to the first embodiment. 5 is an example of a display screen displayed on a terminal display unit of a user terminal device according to the first embodiment. 1 is an example of a display screen 1 displayed on a display unit when a reserved product is received in the product provision processing device according to the first embodiment. 13 is an example of a display screen 2 displayed on a display unit when a reserved product is received in the product provision processing device according to the first embodiment. 13 is an example of a display screen displayed on a display unit when a replenishing operation is performed in the product providing processing device according to the first embodiment. 13 is a sequence diagram illustrating an example of a process transition when a reservation is accepted in the product provision system according to the second embodiment. 13 is a sequence diagram illustrating an example of a process transition during reservation receipt in the product provision system according to the second embodiment.

Embodiments of the present invention will be described in detail below with reference to the drawings. The embodiments described below are merely examples of the present invention and do not limit the content of the present invention. Furthermore, not all of the configurations and operations described in each embodiment are necessarily essential as the configurations and operations of the present invention.

In this embodiment, the direction facing the user when the user operates the product processing device is referred to as the "front," and the direction opposite the front is referred to as the "rear." Also, in this embodiment, the vertical direction/height direction of the product processing device is referred to as the "up-down direction," and the horizontal direction/width direction of the product processing device is referred to as the "left-right direction."

[Embodiment 1]
A product provision system 1 and a product provision processing device 100 according to a first embodiment of the present invention will be described. The product provision processing device 100 according to the first embodiment is a product provision processing device capable of providing medicines as products. In particular, the product provision processing device 100 according to the first embodiment is a product provision processing device capable of providing medicines of various sizes, and is a product provision processing device that can provide the medicines to the user without applying excessive shock to the medicines to be provided.

In addition, the product provision processing device 100 in embodiment 1 is of two types: a first product provision processing device 100A (a so-called vending machine) equipped with a payment unit used to pay for products, and a second product provision processing device 100B installed inside a retail store such as a convenience store and not equipped with a payment unit.
In addition, when no distinction is made between the first product provision processing device 100A and the second product provision processing device 100B, and the components and control contents that are common to both the first product provision processing device 100A and the second product provision processing device 100B are described, they will be referred to as product provision processing device 100.

[External configuration of product provision processing device]
First, a description will be given of the external configuration of the product providing processing device 100 according to embodiment 1. Fig. 1 is an example of a perspective view of the product providing processing device 100 according to embodiment 1 when the door 3 is closed, and Fig. 2 is an example of a perspective view of the product providing processing device 100 according to embodiment 1 when the door 3 is open. Also, Fig. 3 is an example of a schematic diagram showing the configuration of a side view of the product providing processing device 100 according to embodiment 1.

Figure 1(a) is an example of a perspective view of the first product processing device 100A when the door 3 is closed, and Figure 1(b) is an example of a perspective view of the second product processing device 100B when the door 3 is closed.

As shown in FIG. 1(a), a door 3 is provided on the front of the housing 2 of the first product provision processing device 100A. In the first product provision processing device 100A, the door 3 is opened so that a replenishing person can carry out tasks such as replenishing medicines and collecting the payment for the medicines.

On the front side of the door 3, there is a touch screen consisting of a display unit 10 that displays information such as drug descriptions and code information such as QR codes (registered trademark), and an operation input unit 11 that accepts selection operations by the user.

In addition, a product outlet 12 is provided on the front side of the door 3, through which the user can take out the medicines they have purchased. An opening and closing door 13 is pivoted in front of and at the top end of this product outlet 12 to prevent the intrusion of dust, sand, and pests.

In this embodiment, the product outlet 12 is provided in a slightly central portion of the door 3. This allows the user to take out the purchased medicine in a stable position without bending the back or knees. The product outlet 12 may be provided in a lower portion of the door 3 or in an upper portion of the door 3.

In addition, a speaker 19 for outputting sound and the like, and an external camera 20 for photographing the user are provided at the upper part of the front side of the door 3.

The first product processing device 100A has, on the front side of the door 3, a coin insertion unit 14 for accepting coins, a bill validation unit 15 for accepting paper money, and a card payment unit 16 for accepting monetary information on a card, which serve as payment units. Furthermore, a receipt printer 17 for outputting receipts and a change outlet 18 for taking out change are provided.

As shown in FIG. 1(b), the second product provision processing device 100B, like the first product provision processing device 100A, has a door 3 on the front of the housing 2 of the second product provision processing device 100B, and a display unit 10, an operation input unit 11, a product removal opening 12, a speaker 19, and an external camera 20 are provided on the front side of the door 3. However, unlike the first product provision processing device 100A, the second product provision processing device 100B does not have a payment unit (coin insertion unit 14, bill validation unit 15, card payment unit 16, receipt printer 17, change removal opening 18). Accounting for medicines provided by the second product provision processing device 100B is carried out at the store where the second product provision processing device 100B is installed.

As shown in FIG. 2, inside either the first product processing device 100A or the second product processing device 100B, there are provided a number of storage sections 30 that store pharmaceuticals according to the type of pharmaceutical P and are partitioned by a number of storage lanes R1-R4 in the left-right direction and a number of storage levels D1-D10 in the up-down direction. In this embodiment, it is possible to provide 40 storage sections 30 partitioned by four storage lanes R1-R4 and ten storage levels D1-D10, but the number of storage lanes and storage levels can be freely modified as appropriate. For example, there may be six storage lanes and six storage levels.

The multiple storage sections 30 are each formed with approximately the same structure, and are arranged so that their width and length directions are aligned with the width and front-rear directions of the product providing and processing device 100, respectively. In addition, each storage section 30 is removable from the product providing and processing device 100, and is capable of storing medicines of various sizes according to the size of the medicine.

For example, as shown in FIG. 2, by removing the storage section 30 separated by the third storage lane R3 and the sixth storage stage D6, it is possible to store medicines Ph that are tall in the vertical direction in the storage section 30 separated by the third storage lane R3 and the seventh storage stage D7. Also, like the two storage sections 30 separated by the first storage lane R1 and the second storage lane R2, and the fifth storage stage D5, it is possible to store a wide medicine Pw across two storage sections 30. In this way, the product provision processing device 100 of this embodiment can provide medicines of various sizes according to the size of the medicine.

As shown in FIG. 3, each storage section 30 is provided with a conveyor 31 that transports the medicine P stored in the storage section 30 forward, and a pusher 32 that pushes the medicine P placed on the conveyor 31 forward. Note that medicines P stored across multiple storage sections 30 are driven by multiple conveyors 31 simultaneously.

Inside the product processing device 100, an elevator 40 is provided, which is disposed between the door 3 and the multiple storage sections 30 and is configured to be able to move up and down along the vertical direction of the product processing device 100. The elevator 40 receives medicines transported from the storage sections 30 and transports the received medicines to the product removal opening 12.

2 and 3, the elevator 40 is formed in a square tube shape with opening edges on both ends in the front-rear direction of the product providing and processing device 100. More specifically, the elevator 40 is formed in a square tube shape and includes a tray 41 on which medicines transported from the storage section 30 can be placed, a flat ceiling plate 42 arranged opposite to and above the tray 41, and side plates 43 provided on both ends in the left-right direction of the tray 41 and the ceiling plate 42 and connecting the tray 41 and the ceiling plate 42.

The length of the tray 41 in the left-right direction is greater than or equal to the width of all storage lanes R1 to R4 in the left-right direction, and wide medicines Pw stored across multiple storage lanes can be placed on the tray 41. Furthermore, as shown in FIG. 3, the tray 41 is gently inclined toward the front, so that medicines transported to the tray 41 slide down into the product outlet 12, making it easy for the user to take out the medicines provided from the product outlet 12.

The vertical length of the side panel 43 is approximately the same as the height H of two vertically adjacent storage levels, so that tall pharmaceuticals Ph stored across two storage levels can be placed on the tray 41.

The internal camera 21 that photographs the storage unit 30 is mounted on the ceiling board 42. As shown in FIG. 3, an opening 42a that is inclined downward toward the storage unit 30 is formed in the mounting area of the ceiling board 42 on which the internal camera 21 is mounted. Through this opening 42a, the internal camera 21 can photograph the storage unit 30, which is located opposite the elevator 40, and the medicines stored in the storage unit 30.

In this embodiment, the internal camera 21 is mounted on the ceiling board 42, but the location of the internal camera 21 is not limited to the ceiling board 42 as long as the internal camera 21 can capture images of the medicines stored in the storage unit 30.

In addition, inside the product processing device 100, a barrier shelf 50 is provided that faces the product outlet 12, is located behind the elevator 40, is positioned above and below the storage section 30, and is formed in a roughly L-shape when viewed from the side of the product processing device 100.

The barrier shelf 50 has a flat barrier section 51 parallel to the vertical direction of the product processing device 100, and a flat shelf section 52 perpendicular to the vertical direction of the product processing device 100, and a control board 53 used to control the product processing device 100 is placed on the shelf section 52.

As shown in FIG. 3, the elevator 40 waits in a waiting position between the product outlet 12 and the barrier shelf 50 before dispensing the medicine.

When the elevator 40 is waiting in the waiting position, the barrier portion 51 is configured to block the opening edge on the rear side of the elevator 40 so that at least the products cannot pass through the gap between the opening edge on the rear side of the elevator 40 and the barrier portion 51. As a result, when the elevator 40 is waiting in the waiting position, even if someone tries to illegally remove products by reaching into the product removal opening 12 of the product providing and processing device 100, the elevator 40 is formed in a rectangular tube shape, and the tray 41 and ceiling panel 42 act as walls in the vertical direction, the side panel 43 acts as a wall in the horizontal direction, and the barrier portion 51 acts as a wall in the rear direction, preventing the illegal removal of products.

In addition, since the control board 53 is placed on the shelf portion 52 of the barrier shelf 50, the limited space inside the product processing device 100 can be effectively utilized. In addition, since the barrier shelf 50 is located approximately in the center of the product processing device 100 in the vertical direction, the control board 53 can be protected even if the product processing device 100 becomes flooded.

Furthermore, with regard to the operation of the elevator 40, the waiting position of the elevator 40 is located slightly toward the center (approximately the center position) of the storage levels D1 to D10 in the vertical direction, so that the ascending and descending distance from the waiting position to the storage level D of the storage unit 30 where the medicines to be provided are stored can be shortened, and the speed at which the medicines are provided can also be improved.

As shown in Figures 2 and 3, a shutter mechanism 90 is provided on the rear surface of the door 3 and above the product outlet 12 to open and close the opening and closing door 13 pivotally supported by the product outlet 12.

As shown in Figures 2 and 3, in the first product provision processing device 100A, a monetary information input/output unit 60 is provided on the back of the door 3, which is connected to the coin insertion unit 14, bill validation unit 15, card payment unit 16, receipt printer 17, and change outlet 18, and inputs and outputs monetary information, card information, and change information.

Note that the second product provision processing device 100B is different from the first product provision processing device 100A in that it does not have a payment unit and therefore does not have a monetary information input/output unit 60.

[Internal configuration of product provision system]
Next, a description will be given of the internal configuration of a product provision system in which a medicine is selected by a user's terminal device 200 and the medicine is provided via the product provision processing device 100. Fig. 4 is an example of a block diagram showing the configuration of the product provision system 1 according to the first embodiment.

As shown in FIG. 4, the product provision system 1 according to the first embodiment is composed of a plurality of product provision processing devices 100 (a first product provision processing device 100A and a second product provision processing device 100B), a user terminal device 200 operated by a user, a server 300 that performs various processes, and a plurality of pharmacist terminal devices 340 operated by pharmacists who are responsible for providing pharmaceuticals. The server 300 is connected so that the product provision processing devices 100, the user terminal devices 200, and the pharmacist terminal devices 340 can communicate with each other via a public line.

The first product provision processing device 100A includes at least a display unit 10, an operation input unit 11, a speaker 19, an external camera 20, an internal camera 21, a conveyor 31, an elevator 40, a monetary information input/output unit 60, a control unit 70, a communication unit 80, a memory unit 81, and a shutter mechanism 90. In this embodiment, the control unit 70, the communication unit 80, and the memory unit 81 are mounted on a control board 53 (see FIG. 3).

The conveyor 31 is equipped with a belt drive unit 34 consisting of a motor that drives the belt on which the medicines are placed, and a belt position sensor 35 for detecting the position of the belt.

The elevator 40 is equipped with an elevator drive unit 44 consisting of a motor that raises and lowers the elevator 40 in the vertical direction, and an elevator sensor 45 for determining the position of the elevator 40.

The shutter mechanism 90 includes an opening/closing drive unit 91 consisting of a motor that opens and closes the opening/closing door 13 that is pivoted to the product outlet 12, and a shutter sensor 92 for detecting the open/closed state of the opening/closing door 13.

The control unit 70 is composed of a processor such as a CPU (Central Processing Unit) and executes a predetermined control program stored in the memory unit 81 to perform various controls for providing pharmaceuticals.

The control unit 70 is connected to the operation input unit 11, the belt position sensor 35, and the elevator sensor 45 via an input port (not shown) of the control board 53, and is configured to be able to input various information from these devices to the control unit 70. The control unit 70 is also connected to the display unit 10, the belt drive unit 34, and the lift drive unit 44 via an output port (not shown) of the control board 53, and is configured to be able to output various information from the control unit 70 to these devices. The control unit 70 is also connected to the external camera 20, the internal camera 21, the money information input/output unit 60, and the communication unit 80 via an input/output port (not shown) of the control board 53, and is configured to be able to input and output various information between the control unit 70 and these devices.

The communication unit 80 is composed of a communication module that establishes a communication state between the first product provision processing device 100A and the server 300 (the product provision server 310 described later) to enable mutual communication, and the communication method can be either wired communication or wireless communication.

The memory unit 81 is a non-volatile memory storage device that stores control programs and temporary information used by the control unit 70 to perform various controls.

Like the first product provision processing device 100A, the second product provision processing device 100B also includes a display unit 10, an operation input unit 11, a speaker 19, an external camera 20, an internal camera 21, a conveyor 31 (belt drive unit 34, belt position sensor 35), an elevator 40 (lift drive unit 44, elevator sensor 45), a control unit 70, a communication unit 80, and a memory unit 81. However, unlike the first product provision processing device 100A, the second product provision processing device 100B does not include a payment unit and therefore does not include a monetary information input/output unit 60.

The user terminal device 200 is a terminal device such as a personal computer, tablet, or smartphone, and is operated by a user. The user terminal device 200 includes at least a terminal control unit 201, a terminal storage unit 202, a terminal input unit 203, a terminal display unit 204, and a code reading unit 205.

The terminal control unit 201 is made up of a processor such as a CPU, and performs various controls in response to user operations. In particular, the terminal control unit 201 accesses the server 300 (the product provision server 310 described below) and controls the product provision server 310 to select medicines.

The terminal storage unit 202 consists of a readable/writable non-volatile flash memory, and stores various information received from the product providing server 310.

The terminal input unit 203 consists of an input unit such as a keyboard or a touch panel, and can input information related to user operations.

The terminal display unit 204 consists of an image display device that displays images, such as a liquid crystal display or an organic EL display, and is capable of displaying images according to user operations and images received from the product providing server 310.

The code reading unit 205 is a code reader that can read the code information displayed on the display unit 10 of the product provision processing device 100 and analyze the read code information.

The server 300 is composed of a product provision server 310, a pharmacist server 320, and a database storage unit 330.

The product provision server 310 is a server that performs processing to provide medicines, and is connected to the product provision processing device 100, the user terminal device 200, the pharmacist server 320, and the database storage unit 330. The product provision server 310 selects medicines for the user terminal device 200 in response to operation instructions from the user terminal device 200, and transmits map information on the location of the product provision processing device 100 to the user terminal device 200. The product provision server 310 also permits the product provision processing device 100 to provide medicines. The product provision server 310 also instructs the pharmacist server 320 to have a pharmacist approve the request.

The pharmacist server 320 is a server that performs processing related to the pharmacist terminal device 340, and is connected to the product provider server 310, the database storage unit 330, and the pharmacist terminal device 340. The pharmacist server 320 keeps track of the number of accesses to the pharmacist terminal device 340, has the pharmacist approve the request, and pays incentives to the pharmacist terminal device 340.

The database storage unit 330 is made up of a large-capacity storage device such as a hard disk drive (HDD), a solid state drive (SDD), an optical disk drive, a magnetic tape device, etc., and stores various information for providing medicines. Specifically, the database storage unit 330 stores various information for providing medicines, such as "medicine information," "reserved product information," "provided product information," and "user image" associated with user-specific information, location information associated with product provision processing device-specific information, product inventory, storage unit provision status (storage unit provision permitted status, storage unit provision suspended status), sample replenishment product image information, and pharmacist-specific information.

In this embodiment, "pharmaceutical information" includes the classification of various pharmaceuticals (class 1 pharmaceuticals, class 2 pharmaceuticals, or class 3 pharmaceuticals), information on ingredients contained in various pharmaceuticals, prohibited combinations of various ingredient information that are contraindicated for combined use, caution combinations of various ingredient information that are cautioned for combined use, sample product images of various pharmaceuticals, etc. Furthermore, "information on reserved products" includes the reserved pharmaceuticals, the number of reserved items, the time of completion of the reservation, unique information of the pharmacist who conducted the consultation, etc. Furthermore, "information on provided products" includes the provided pharmaceuticals, the number provided, the time of provision, and unique information of the product provision processing device that provided them.

In this embodiment, the product providing server 310 and the pharmacist server 320 are configured separately, but the product providing server 310 may have the functions of the pharmacist server 320 and may be configured as a single server. Furthermore, the servers may be divided into more detailed functions and configured as three or more servers.

The pharmacist terminal device 340 is a terminal device such as a personal computer, tablet, or smartphone, and is operated by a pharmacist.

The pharmacist terminal device 340 also has an identity authentication function that uses biometric authentication such as a camera to authenticate whether or not the pharmacist is a pre-registered pharmacist. This identity authentication function performs identity authentication each time the pharmacist logs into the pharmacist terminal device 340, when the pharmacist performs various approval tasks, etc. This makes it possible to prevent approval actions by anyone other than a qualified pharmacist.

[Product provision system sequence diagram]
Next, a description will be given of a process transition of the product provision system 1. Fig. 5 is an example of a sequence diagram showing a process transition when a reservation is accepted by the product provision system according to the first embodiment, and Fig. 6 is an example of a sequence diagram showing a process transition when a reservation is received by the product provision system according to the first embodiment.

The sequence diagrams shown in Figures 5 and 6 show, from the left, the processing of the user terminal device 200, the product provision processing device 100, the server 300 (product provision server 310 and pharmacist server 320), and the pharmacist terminal device 340. Note that for each process described below, the elements of step S are illustrated in an exemplary order, and are not limited to the specific order illustrated. Therefore, in the flowcharts shown in Figures 5 and 6, the order can be changed as long as no inconsistencies arise in the processing results. The same applies to Figures 7 to 10, 15, and 16 described below.

(Sequence when accepting reservations)
A case where the user decides to reserve a medicine through the user terminal device 200 will be described.

As shown in FIG. 5, when a user logs in to the product providing server 310, the user terminal device 200 performs a product selection login process (step S1).
In this product selection login process, first, the user's unique information such as a password is transmitted to the product providing server 310 .

When the product providing server 310 receives the user's unique information from the user terminal device 200, the product providing server 310 performs a user authentication process (step S31).
In this user authentication process, it is determined whether the user's unique information received from the user terminal device 200 is unique to a user registered in the database storage unit 330. Then, user authentication result information indicating whether the received user's unique information is unique to a registered user is transmitted to the user terminal device 200. If the received user's unique information is unique to a user registered in advance, the user authentication is deemed successful, the received user's unique information is registered as unique information of the accessing user, and a communication state between the product providing server 310 and the user terminal device 200 is established.

When the user terminal device 200 receives the user authentication result information indicating that the user authentication has been successful, the user terminal device 200 performs a reserved product determination process for determining the medicine provided by the product provision processing device 100 as the reserved product (step S2).
In this reserved product determination process, a medicine is selected based on the name of the medicine or based on symptoms, and the medicine provided by the product provision processing device 100 is determined as a reserved product.

After the reserved product is determined, the user terminal device 200 performs a specific reserved product determination process to determine whether the reserved product is a specific medicine (step S3).
In this specific reserved product determination process, it is determined whether the reserved product is a specific drug (e.g., a first-class drug). If it is determined that the reserved product is a specific drug, the process proceeds to the medical interview request process in step S4, whereas if it is determined that the reserved product is not a specific drug but a normal drug (e.g., an OTC drug such as a second or third-class drug), the process proceeds to the normal reserved product confirmation process in step S6 without performing the processes in steps S4 and S5.

In addition, if the user terminal device 200 determines that the medicine decided as the reserved item is a specific medicine, it performs an interview request process to have the user conduct an interview with a pharmacist regarding the specific medicine (step S4).
In this medical interview request process, the reserved product information of the specific medicine determined as the reserved product, medical interview request information requesting a medical interview with a pharmacist, and the like are transmitted to the product providing server 310.

When the product provision server 310 receives the reserved product information, medical interview request information, etc., it transfers the reserved product information, medical interview request information, etc. to the pharmacist server 320.

When the pharmacist server 320 receives the reserved product information, the medical interview request information, and the like via the product providing server 310, it performs a medical interview reception start process for receiving a medical interview from the pharmacist (step S32).
In this inquiry reception start process, inquiry reception information notifying all pharmacist terminal devices 340 that a user inquiry will be made is transmitted.

When the pharmacist terminal device 340 receives medical interview reception information from the pharmacist server 320, it is notified that a medical interview is available for the user.

When a pharmacist wishes to ask a question of a user, the pharmacist terminal device 340 first performs a pharmacist login process to log in to the pharmacist server 320 (step S51).
In this pharmacist login process, first, the pharmacist is authenticated by biometric authentication using a camera or the like mounted on the pharmacist terminal device 340 , and if the authentication is successful, the pharmacist's unique information is sent to the pharmacist server 320 .

When the pharmacist server 320 receives the pharmacist's unique information from the pharmacist terminal device 340, the pharmacist server 320 performs a pharmacist authentication process to authenticate the received pharmacist's unique information (step S33).
In this pharmacist authentication process, it is determined whether the received pharmacist's unique information is unique information of a pharmacist registered in the database storage unit 330, and if the received pharmacist's unique information is unique information of a registered pharmacist, it is determined that the authentication of the pharmacist has been successful. Then, pharmacist authentication result information indicating the authentication result of the pharmacist is transmitted to the pharmacist terminal device 340. Furthermore, if the authentication of the pharmacist is successful, the received pharmacist's unique information is registered as unique information of the pharmacist currently accessing the pharmacist server 320, and the access count of the pharmacist currently accessing the pharmacist server 320 is updated.

When the pharmacist terminal device 340 receives pharmacist authentication result information from the pharmacist server 320 indicating that the pharmacist authentication was successful, it can request a user interview, as described below.

When the user requests a medical interview, the pharmacist terminal device 340 performs a medical interview request process (step S52).
In this medical interview application process, the pharmacist's identity is authenticated using biometric authentication such as a camera mounted on the pharmacist terminal device 340, and if the authentication is successful, the medical interview application information and the pharmacist's unique information are sent to the pharmacist server 320.

When the pharmacist server 320 receives the medical interview application information and the pharmacist's unique information, it performs a medical interview allocation process (step S34) to determine whether or not to permit a medical interview application from any of the pharmacist terminal devices 340.
In this interview allocation process, the pharmacist terminal device 340 that first sent interview application information to the pharmacist server 320 is permitted to apply for the user's interview (so-called first come, first served), and a communication state is established between the pharmacist terminal device 340, the pharmacist server 320, and the user terminal device 200. This makes it possible to shorten the waiting time for a pharmacist to participate in the user's interview. In addition, interview application result information indicating whether the interview application from the pharmacist terminal device 340 has been permitted is transmitted to the pharmacist terminal device 340.

The user terminal device 200 performs an interview process to ask a question to the pharmacist terminal device 340 with which communication has been established (step S5).
In this medical interview process, the user answers questions posed by the pharmacist at the pharmacist terminal device 340 using text-based means such as chat or voice conversation, and information on the answered questions is sent to the pharmacist server 320.

The pharmacist server 320 performs a medical interview content transmission process (step S35) to transmit the medical interview content from the user terminal device 200.
In this medical interview content transmission process, medical interview content information indicating the medical interview content from the user is transmitted to the pharmacist terminal device 340 that has permitted the user's application for a medical interview.

When the pharmacist operates the medical interview result based on the contents of the medical interview from the user, the pharmacist terminal device 340 performs a pharmacist first approval process to send first approval result information indicating the medical interview result to the pharmacist server 320 (step S53).
In this pharmacist first approval process, when an approval operation is performed by a pharmacist to approve a specific medicine, first approval information is sent to the pharmacist server 320 as first approval result information, and when a denial operation is performed by the pharmacist to not approve the specific medicine, first denial information is sent to the pharmacist server 320 as first approval result information.

When the pharmacist server 320 receives the first approval result information from the pharmacist terminal device 340, it performs a first incentive payment process (step S36).
In this first incentive payment process, first, the unit price of the incentive is set based on the current number of accesses by the pharmacist. Then, a payment process is performed in which the first incentive, which is a part (e.g., 50%) of the set unit price of the incentive, is sent to the pharmacist terminal device 340 as electronic money or transferred to the pharmacist's bank account so as to be paid to the pharmacist who approved the specific drug. Furthermore, the pharmacist server 320 transfers the first approval result information received from the pharmacist terminal device 340 to the product provision server 310.

Here, it is desirable to set the incentive unit price high during times when pharmacists are less likely to access the system, such as late at night or on holidays, and set the incentive unit price low during times when pharmacists are more likely to access the system, such as during the day or on weekdays. This makes it possible to automatically control the setting of the incentive unit price during times when there is less access, and ensures that pharmacists can stably carry out approval work during times such as late at night or on holidays.

In addition, a portion of the incentive will be paid to the pharmacist who first sends the medical interview application information to the pharmacist server 320 and approves the specific drug.

When the product providing server 310 receives the first approval result information from the pharmacist terminal device 340 via the pharmacist server 320, the product providing server 310 performs a specific reserved product confirmation process (step S37).
In this specific reserved product confirmation process, when first approval information is received as the first approval result information, the specific medicine determined as the reserved product is confirmed, and when first denial information is received as the first approval result information, the information of the specific medicine determined as the reserved product is discarded.

When the user terminal device 200 determines that the medicine determined as the reserved product is a normal medicine and not a specific medicine, it performs a normal reserved product confirmation process to confirm the normal medicine determined as the reserved product (step S6). Note that when it is determined that the medicine determined as the reserved product is a specific medicine, the normal reserved product confirmation process is not performed.
In this reservation result process, information about the reserved product determined as the reserved product, user specific information, and the like are transmitted to the product providing server 310 .

The product providing server 310 performs a reserved product registration process to register information about the confirmed reserved product in the database storage unit 330 (step S38).
In this reserved product registration process, the registration information of the reserved product (reserved medicine, reserved quantity, reservation completion time, and unique information of the pharmacist who interviewed the patient) is registered in the database storage unit 330 in association with the unique information of the user.

After performing the reserved product registration process, the product providing server 310 performs a location information extraction process to extract location information of the product providing processing device 100 that can provide the reserved product (step S39).
In this location information extraction process, information about the product provision processing device 100 stored in the database storage unit 330 is referenced, and unique information of the product provision processing device in which the product corresponding to the reserved product is in stock and the storage unit 30 storing the product corresponding to the reserved product is in a storage unit provision permitted state is extracted. Then, location information associated with the extracted unique information of the product provision processing device is extracted, and the extracted location information is transmitted to the user terminal device 200. In this way, since the location information of the product provision processing device 100 in which the product is in stock and in a storage unit provision permitted state is extracted, it is possible to reduce the chance of being unable to receive the reserved medicine when receiving it because the product provision processing device 100 is sold out or is not in a supplying state. Furthermore, in the location information extraction process, registration information of the reserved product registered by the reserved product registration process is transmitted to the user terminal device 200.

When the user terminal device 200 receives the registration information of the reserved item and the location information of the product provision processing device 100 from the product provision server 310, it performs a reservation result list display process to display the registration information of the reserved item and the location information of the product provision processing device 100 (step S7).
In this reservation result list display process, first, the received registration information of the reserved item is stored in the terminal storage unit 202. Then, based on the registration information of the reserved item and the location information of the product provision processing device 100, an explanatory image showing the registration information of the reserved item and a location information image showing the location of the product provision processing device are displayed on the terminal display unit 204. This explanatory image makes it possible to confirm which medicines have been reserved, and the display of the location information image allows the user to know where to go to receive the medicines from the product provision processing device 100.

(Reservation pick-up sequence)
Next, a case where the user receives the reserved product from the product supply processing device 100 will be described.

As shown in FIG. 6, the product supply processing device 100 performs a reception waiting process for receiving an operation from a user or the like (step S11).
In this reception waiting process, the type of operation from the user is determined, and if the user performs an operation to receive the reserved item, the process proceeds to an authentication code information display process (step S12).

When the user performs an operation to receive the reserved product, the product supply processing device 100 performs an authentication code information display process (step S12).
In this authentication code information display process, authentication code information is displayed on the display unit 10 of the product provision processing device 100. This "authentication code information" includes reservation connection information (URL) for connecting to the product provision server 310, unique information of the product provision processing device, reservation product call instruction information for calling up registration information of the reserved product stored in the terminal storage unit 202 of the user terminal device 200, and the like.

When the authentication code information is displayed on the display unit 10 of the product supply processing device 100, the user terminal device 200 performs an authentication code information reading process (step S8).
In this authentication code information reading process, the authentication code information displayed on the display unit 10 of the product provision processing device 100 is read, the read authentication code information is analyzed, and the analyzed authentication code analysis information (reservation connection information, information unique to the product provision processing device, reserved product call instruction information, etc.) is obtained. Then, based on the reserved product call instruction information included in the authentication code analysis information, the registration information of the reserved product stored in the terminal storage unit 202 is called up.

After acquiring the authentication code analysis information, the user terminal device 200 performs a reservation registration information transmission process (step S9).
In this reservation registration information transmission process, the product providing server 310 is accessed based on the reservation connection information contained in the authentication code analysis information, and the registration information of the called-up reserved product, the user's unique information, the product provision processing device's unique information contained in the authentication code analysis information, etc. are transmitted to the product providing server 310.

When the product providing server 310 receives the registration information of the reserved product, the user's unique information, the product providing processing device's unique information, and the like from the user terminal device 200, it performs a destination allocation process (step S41).
In this destination allocation process, the registration information of the reserved product, the user's unique information, etc. are transmitted to the product supply processing device 100 having the unique information of the product supply processing device that received the information.

When the product provision processing device 100 receives the registration information of the reserved product, the user's unique information, and the like from the product provision server 310, the product provision processing device 100 performs a product grade determination process (step S13).
In this product grade determination process, it is determined whether the reserved medicine is a "medicine requiring caution" based on the registered information of the reserved product.

"Drugs requiring caution" are not limited to the specific drugs mentioned above (for example, Category 1 drugs), but also include OTC drugs that may cause health damage if the ingredients contained in them are abused in excess of the appropriate dosage, and drugs that may cause health damage when combined with ingredients of other drugs (caution for combined use/contraindication for combined use). This refers to drugs that may cause health damage in a broader sense than the specific drugs mentioned above.

If the product provision processing device 100 determines in the product grade determination process that the reserved drug is a drug requiring caution, it proceeds to the OTC drug eligibility determination process in step S14, and if it determines that the reserved drug is not a drug requiring caution, it proceeds to the provided product confirmation process in step S18 without performing the processes in steps S14 to S16.

When the product provision processing device 100 determines that the reserved drug is a drug that requires caution, it performs a process of determining whether the drug is an OTC drug (step S14).
In this OTC drug target determination process, it is determined whether the OTC drug is a target drug for which health damage should be suppressed. If it is determined that the OTC drug is a target drug for which health damage should be suppressed, the process proceeds to OTC drug health damage prevention process in step S15, and if it is determined that the OTC drug is not a target drug for which health damage should be suppressed, the process proceeds to user photography process in step S16.

When the product provision processing device 100 determines that the OTC drug is a drug for which health hazard prevention is required, the product provision processing device 100 performs a process for preventing health hazards of the OTC drug (step S15).
In this OTC drug health damage prevention process, an abuse prevention judgment process is performed to determine whether or not a prescribed number of drugs containing the drug ingredient information to be provided have been provided within a prescribed period, and a contraindication prevention judgment process is performed to determine whether or not the drug ingredient information to be provided and past drug ingredient information are a contraindicated combination or a caution combination. The details of this OTC drug health damage prevention process will be described later with reference to FIG. 9.

If the product provision processing device 100 determines that the reserved medicine is a medicine that requires caution, it performs a user photographing process to photograph the user using the external camera 20 (step S16).

When the user is photographed by the external camera 20, the product supply processing device 100 performs supply application processing (step S17).
In this supply application process, supply application information for applying to a pharmacist for approval to supply a medicine, a user image captured by the external camera 20, user specific information, etc. are transmitted to the product supply server 310.

When the product provision server 310 receives the provision application information, the user image, the user's unique information, etc., it extracts the registration information of the reserved product that corresponds to the user's unique information, and transmits the extracted registration information of the reserved product, together with the provision application information, the registration information of the reserved product, the user image, the user's unique information, etc. received from the product provision processing device 100 to the pharmacist server 320.

When the pharmacist server 320 receives the registration information of the reserved product, the supply application information, the user image, the user's unique information, and the like via the product supply server 310, it performs a supply approval acceptance process (step S42).
In this supply approval reception process, if the medicine included in the registration information of the reserved product is a specific medicine, the unique information of the inquiring pharmacist included in the registration information of the reserved product is extracted, and supply approval reception information notifying the approval work regarding the supply of the medicine is transmitted to the pharmacist terminal device 340 having the unique information of the inquiring pharmacist. In addition, in the supply approval reception process, if the medicine included in the registration information of the reserved product is not a specific medicine (if it is a normal medicine that requires caution), the supply approval reception information is transmitted to all pharmacist terminal devices 340.

When the pharmacist terminal device 340 receives the supply approval acceptance information from the pharmacist server 320, it is notified that approval work is required regarding the supply of a medicine.

When a pharmacist wishes to perform approval work regarding the provision of medicines, the pharmacist terminal device 340 performs the above-mentioned pharmacist login process (step S51), and the pharmacist server 320 performs the above-mentioned pharmacist authentication process (step S33). In addition, when the pharmacist terminal device 340 receives pharmacist authentication result information from the pharmacist server 320 indicating that the pharmacist authentication was successful, the pharmacist terminal device 340 can apply for approval work regarding the provision of medicines.

When applying for approval of the supply of medicines, the pharmacist terminal device 340 performs supply approval application processing (step S54).
In this supply approval application process, the pharmacist's identity is authenticated using biometric authentication such as a camera mounted on the pharmacist terminal device 340, and if the authentication is successful, the supply approval application information and the pharmacist's unique information are sent to the pharmacist server 320.

When the pharmacist server 320 receives the supply approval application information and the pharmacist's unique information, it performs a supply approval allocation process (step S44) to determine whether or not to approve the application for approval work from any of the pharmacist terminal devices 340.
In this supply approval allocation process, if the medicine included in the registration information of the reserved product is a specific medicine, the pharmacist terminal device 340 corresponding to the unique information of the questioning pharmacist included in the registration information of the reserved product is permitted to apply for approval work. Also, in the supply approval allocation process, if the medicine included in the registration information of the reserved product is a normal medicine that requires caution, the pharmacist terminal device 340 that first transmitted the supply approval application information to the pharmacist server 320 is permitted to apply for approval work. Then, supply approval application result information indicating whether the application for approval work from the pharmacist terminal device 340 has been permitted is transmitted to the pharmacist terminal device 340, and the registration information of the reserved product, the user image, the unique information of the user, etc. are transmitted to the pharmacist terminal device 340 that permitted the application for approval work.

The pharmacist terminal device 340 receives the registration information of the reserved item, the user image, the user's unique information, etc., allowing the pharmacist to check the registration information of the reserved item, the user image, etc., and perform approval work regarding the provision of the medicine.

When the pharmacist performs the approval operation regarding the provision of the medicine, the pharmacist terminal device 340 performs a second pharmacist approval process in which second approval result information indicating the approval result is transmitted to the pharmacist server 320 (step S55).
In this pharmacist second approval process, when an approval operation to approve the provision of the medicine is performed, second approval information is transmitted to the pharmacist server 320 as second approval result information, and when a denial operation to deny the provision of the medicine is performed, second denial information is transmitted to the pharmacist server 320 as second approval result information. Then, the pharmacist server 320 that has received the second approval result information transfers the second approval result information to the product provision server 310.

In this embodiment, the second pharmacist approval process is performed even when the drug included in the registration information of the reserved product is a regular drug (OTC drug) that requires caution, but the second pharmacist approval process may be performed only when the drug included in the registration information of the reserved product is a specific drug (for example, a Category 1 drug). When configured in this way, when the drug included in the registration information of the reserved product is a regular drug, the processes of steps S17, S42, etc. described above do not need to be performed.

When the product provider server 310 receives the second approval result information from the pharmacist terminal device 340 via the pharmacist server 320, the product provider server 310 performs a provision approval result reflection process (step S45).
In this supply approval result reflection process, second approval result information is transmitted to the product supply processing device 100 .

If the reserved medicine is a medicine that does not require caution, or if the reserved medicine is a medicine that requires caution and the product provision processing device 100 receives second approval result information from the product provision server 310, it performs a provided product confirmation process (step S18).
In this provided product confirmation process, if the reserved medicine is a medicine that does not require any precautions, the medicine included in the registration information of the reserved product is confirmed as the medicine to be provided.
In addition, in the process of determining the product to be provided, if the reserved medicine is a medicine requiring caution, when second approval information indicating the pharmacist's approval is received as the second approval result information, the medicine included in the registration information of the reserved product is determined as the medicine to be provided, and when second denial information indicating the pharmacist's denial is received as the second approval result information, the medicine to be provided is not determined, and provision prohibition information is set to prohibit the provision of the reserved product.

When the product provision processing device 100 has confirmed the medicine to be provided, it performs a product provision process to provide the confirmed medicine to the user (step S19). Then, when the provision of the medicine to the user is completed by the product provision process, it transmits to the product provision server 310 provision completion information indicating that the provision of the reserved product has been completed, as well as the user's unique information, etc. Details of this product provision process will be described later with reference to FIG. 10.

When the product provision server 310 receives the provision completion information and the like from the product provision processing device 100, the product provision server 310 performs a product provision completion process (step S46).
In this product provision completion process, information on the provided products (provided medicine, number of provided products, time of provision, and information unique to the product provision processing device) is registered in the database storage unit 330 in association with the unique information of the user. Furthermore, the product provision server 310 transfers the provision completion information and the like to the pharmacist server 320.

When the pharmacist server 320 receives the provision completion information, etc. from the product provision server 310, it performs a second incentive payment process (step S47).
In this second incentive payment process, if the drug is a specific drug, a payment process is performed in which the second incentive, which is the remaining amount (e.g., 50%) of the incentive unit price set by the first incentive payment process in step S36, is sent to the pharmacist terminal device 340 as electronic money or transferred to the pharmacist's bank account to be paid to the pharmacist who performed the approval work for the provision of the drug. Also, in the second incentive payment process, if the drug is a normal drug (OTC drug) that requires caution, a payment process is performed to pay a third incentive that is lower than the second incentive for the specific drug.

In this way, when a user selects a specific medicine as a reserved item, a portion of the incentive is paid to the pharmacist at the time of approval through a medical interview after the reserved item is selected, and the remaining amount of the incentive is paid when the item is provided by the product provision processing device 100. Therefore, even if a user selects a reserved item but cancels the reserved item and the item is not actually provided by the product provision processing device 100, a portion of the incentive is paid at the time of approval through a medical interview, which encourages pharmacists to proactively perform approval tasks and improves the operating rate of the product provision system 1.

When the product provision processing device 100 completes the provision of the medicine to the user through the product provision processing, it performs an inventory quantity calculation processing (step S20).
In this inventory calculation process, the inventory quantity of the medicine stored in the storage unit 30 is calculated, and information on the calculated inventory quantity and unique information of the product provision processing device are transmitted to the product provision server 310 .

When the product provision server 310 receives the information on the stock quantity from the product provision processing device 100, the product provision server 310 performs a stock quantity update process (step S48).
In this inventory update process, the inventory quantity is updated in association with the received unique information of the product providing processing device, and stored in the database storage unit 330 .

Note that the processing of the user terminal device 200, the product provision processing device 100, the server 300 (the product provision server 310 and the pharmacist server 320), and the pharmacist terminal device 340 in the above-mentioned sequence diagram is an example of typical processing, and processing is also performed to fulfill many other functions.

For example, the product provision server 310 transmits sample product images of pharmaceuticals and sample replenishment product images to the product provision processing device 100 for pattern matching, which will be described later.

[Control process of product provision processing device]
Next, a detailed description will be given of the control process of the product supply processing device 100. Fig. 7 is an example of a flowchart showing the main control process of the product supply processing device 100 according to the first embodiment.

(Main control process of the product provision processing device)
The main control process of the product supply processing device 100 shown in FIG. 7 is carried out when power is supplied to the product supply processing device 100 .

As shown in FIG. 7, in step S101, the control unit 70 performs a power interruption recovery process.
In this power interruption recovery process, various information is initialized, communication is confirmed with the product providing server 310, and necessary information is obtained from the product providing server 310. In this embodiment, information on ingredients contained in various medicines, sample product images of various medicines, and sample refill product images when the products are properly refilled in the storage unit 30 are obtained from the product providing server 310 and stored in the memory unit 81. When this process is completed, the process proceeds to step S102.

In step S102, the control unit 70 performs a reception waiting process for receiving operations from a user and operations for replenishing products from a replenishing person.
6 (step S11), and is a process for causing the display unit 10 to display a reception display screen for receiving operations from the user and for waiting for reception of an operation from the user or an operation for replenishing products from a replenisher. When an operation from the user or an operation for replenishing products from a replenisher is received, the process proceeds to step S103.

In step S103, the control unit 70 determines whether or not an operation to start replenishing products has been received from a replenishing person. Examples of operations to start replenishing products from a replenishing person include opening the door 3, unlocking the locked state of the door 3, and inputting a replenishing start password or the like into the operation input unit 11 by the replenishing person.
If the control unit 70 determines that it has received an operation to start replenishing products from the replenisher, it transfers processing to step S104, and if it determines that it has not received an operation to start replenishing products from the replenisher, it transfers processing to step S106.

In step S104, the control unit 70 determines whether or not an operation to end product replenishment has been received from the replenisher. Examples of operations to end product replenishment from the replenisher include closing the door 3, closing and locking the door 3, and inputting a replenishment end password or the like into the operation input unit 11 by the replenisher.
If the control unit 70 determines that an operation to end product replenishment has been received from the replenisher, it transfers processing to step S105, and if it determines that an operation to end product replenishment has not been received from the replenisher, it waits until an operation to end product replenishment is received from the replenisher.

In step S105, the control unit 70 performs a product replenishment confirmation process to confirm whether the replenishment work by the replenisher has been performed correctly. Details of this product replenishment confirmation process will be described later using FIG. 8. When this process ends, the process returns to step S102.

In step S106, the control unit 70 determines whether or not an operation to receive the reserved item has been accepted from the user.
If the control unit 70 determines that a request to receive the reserved item from the user has been accepted, it transfers processing to step S107; if the control unit 70 determines that a request to receive the reserved item from the user has not been accepted, it transfers processing to step S115.

In step S107, the control unit 70 performs an authentication code information display process to display the authentication code information.
This authentication code information display process corresponds to the authentication code information display process (step S12) shown in Fig. 6, and causes the display unit 10 of the product supply processing device 100 to display the authentication code information. When this process ends, the process proceeds to step S108.

In step S108, the control unit 70 determines whether or not the registration information of the reserved item and the user's unique information have been received from the item providing server 310.
If the control unit 70 determines that the registration information for the reserved item and the user's unique information have been received, it transfers processing to step S109; if it determines that the registration information for the reserved item and the user's unique information have not been received, it waits until the registration information for the reserved item and the user's unique information are received.

In step S109, the control unit 70 judges whether the reserved medicine is a medicine requiring caution based on the registration information of the reserved product. The process of step S109 corresponds to the product grade judgment process (step S13) shown in FIG. 6.
If the control unit 70 determines that the reserved medicine is a medicine that requires caution, it transfers processing to step S110, and if it determines that the reserved medicine is not a medicine that requires caution, it transfers processing to step S117.

In step S110, the control unit 70 determines whether the OTC drug is a drug that should be prevented from causing health damage. The process in step S110 corresponds to the process in step S14 of FIG. 6 for determining whether the OTC drug is a drug that should be prevented from causing health damage.
If the control unit 70 determines that the product is a drug for which health damage should be suppressed, it proceeds to step S111; if the control unit 70 determines that the product is not a drug for which health damage should be suppressed, it proceeds to step S112.

In step S111, the control unit 70 performs a process for preventing health damage to OTC drugs. The process in step S111 corresponds to the process for preventing health damage to OTC drugs (step S15) shown in FIG. 6. Details of the process for preventing health damage to OTC drugs will be described later with reference to FIG. 9. When this process ends, the process proceeds to step S112.

In step S112, the control unit 70 performs a user photographing process of photographing the user with the external camera 20. The process in step S112 corresponds to the user photographing process (step S16) shown in FIG.
In this user photographing process, the user is photographed by the external camera 20, and the photographed user image is acquired. When this process ends, the process proceeds to step S113.

In step S113, the control unit 70 performs a provision application process. The process in step S113 corresponds to the provision application process (step S17) shown in FIG.
In this supply application process, supply application information, a user image, user specific information, etc. are transmitted to the product supply server 310. When this process ends, the process proceeds to step S114.

In step S<b>114 , the control unit 70 determines whether or not the second approval result information has been received from the product providing server 310 .
If the control unit 70 determines that the second approval result information has been received, it transfers the processing to step S117, and if it determines that the second approval result information has not been received, it waits until the second approval result information is received.

In step S115, the control unit 70 determines whether or not a product purchase operation has been accepted from the user.
If the control unit 70 determines that a product purchase operation from the user has been accepted, it transfers the processing to step S116, and if it determines that a product purchase operation from the user has not been accepted, it returns the processing to step S102.

In step S116, the control unit 70 performs a product selection process to select a medicine by selecting a medicine from the name of the medicine or by selecting a medicine from symptoms in response to a product selection operation by the user. When this process ends, the process proceeds to step S117.

In step S117, the control unit 70 performs a provided product determination process to determine the medicine to be provided. This provided product determination process corresponds to the provided product determination process (step S18) shown in FIG.
In the provided product determination process, when a product purchase operation from the user is accepted (step S115), a product determination process is performed to determine the selected medicine in response to the product determination operation from the user.
In the provision product confirmation process, when a reception operation of a reserved product from a user is accepted (step S106), if the reserved medicine is a medicine that does not require caution (step S109), the medicine included in the registration information of the reserved product is confirmed as the medicine to be provided in response to the product confirmation operation from the user. Also, when a reception operation of a reserved product from a user is accepted, if the reserved medicine is a medicine that requires caution, when second approval information indicating the pharmacist's approval is received as the second approval result information, the medicine included in the registration information of the reserved product is confirmed as the medicine to be provided in response to the product confirmation operation from the user, and when second denial information indicating the pharmacist's denial is received as the second approval result information, the medicine to be provided is not confirmed, and provision prohibition information that prohibits provision of the product is set.
When this process is completed, the process proceeds to step S118.

In step S118, the control unit 70 performs a product provision process to provide the confirmed medicine from the storage unit 30. This product provision process corresponds to the product provision process (step S19) shown in FIG. 6, and will be described in detail later with reference to FIG. 10. When this process ends, the process proceeds to step S119.

In step S119, the control unit 70 performs an inventory quantity calculation process to calculate the inventory quantity of the medicine stored in the storage unit 30. This inventory quantity calculation process corresponds to the inventory quantity calculation process (step S20) shown in FIG.
In this inventory calculation process, the inventory of the provided medicine is calculated by subtracting the number of provided medicines from the inventory of the medicine before the medicine is provided. When the inventory of the medicine becomes zero, the display unit 10 displays that the medicine is sold out. When this process is completed, the process proceeds to step S120.

In step S120, the control unit 70 performs an inventory information transmission process to transmit information on the inventory quantity of pharmaceuticals and the unique information of the product provision processing device to the product provision server 310. This allows the product provision server 310 to store the inventory quantity in the database storage unit 330 in association with the received unique information of the product provision processing device, and to grasp the inventory quantities of multiple product provision processing devices 100. When this process ends, the process returns to step S102.

Although not shown in the figure, in addition to the main control process shown in Figure 7 as a control process of the product provision processing device 100, there is also reception interrupt processing that is performed by receiving various information from the product provision server 310.

(Product replenishment confirmation process for product provision processing device)
Next, a description will be given of details of the product replenishment confirmation process of the product supply processing device 100. Fig. 8 is an example of a flowchart showing the product replenishment confirmation process of the product supply processing device 100 according to the first embodiment.

As shown in FIG. 8, in step S121, the control unit 70 performs a replenishment elevator drive process in which the lift drive unit 44 moves the elevator 40 to a position facing any one of the storage levels D1 to D10.
In this refill elevator drive process, the elevator 40 is moved to a position facing a storage level D that is not photographed by the internal camera photographing process described later, so as to move in the order from the top storage level D1 to the bottom storage level D10 (top to bottom) or from the bottom storage level D10 to the top storage level D1 (bottom to top). When this process is completed, the process proceeds to step S122.

In step S122, the control unit 70 performs a replenishment internal camera photographing process in which the internal camera 21 photographs the storage unit 30.
In this internal camera photographing process during replenishment, the internal camera 21 photographs all storage lanes R1 to R4 in the storage level D facing the elevator 40, and obtains photographed images of replenished products in that storage level D. When this process ends, the process proceeds to step S123.

In step S123, the control unit 70 performs a replenishment pattern matching determination process.
In this replenishing pattern matching determination process, pattern matching is performed between the photographed replenishing product image acquired by the replenishing internal camera photographing process and a sample replenishing product image when the product is correctly replenishing in the storage section 30 in the storage shelf D, and it is determined whether or not the wrong product has been replenishing. When this process is completed, the process proceeds to step S124.

In step S124, the control unit 70 determines whether or not the pattern matching (pattern matching determination process during refilling) for all storage stages D1 to D10 has been completed.
If the control unit 70 determines that pattern matching has been completed for all storage stages D1 to D10, it transfers the processing to step S126, and if it determines that pattern matching has not been completed for all storage stages D1 to D10, it returns the processing to step S121.

In this way, by repeating the processing of steps S121 to S124, photographed replenishment product images are obtained for all storage shelves D1 to D10, and pattern matching is performed for all storage shelves D1 to D10.

In step S126, the control unit 70 performs a pattern matching display process during replenishment.
In this refill pattern matching display process, first, the photographed refill product images for all storage shelves D1 to D10 are synthesized to generate an overall photographed refill product image. Then, the judgment result (normal/matching error) of the refill pattern matching judgment process is displayed on the display unit 10, and the overall photographed refill product image and the overall sample refill product image are displayed in comparison on the display unit 10. When this process is completed, the process proceeds to step S127.

In this embodiment, the system is configured to generate an overall photographed replenishment product image from the photographed replenishment product images of all storage stages D1 to D10 captured by the internal camera 21, but it is also possible to photograph all storage sections 30 at once using the internal camera 21, and use the photographed image as the overall photographed replenishment product image.

In step S127, the control unit 70 determines whether or not it has been determined by the restocking pattern matching determination process that the wrong product has been restocked, that is, whether or not a matching error has occurred.
If the control unit 70 determines that a matching error has occurred, the process proceeds to step S128, and if the control unit 70 determines that a matching error has not occurred, the process proceeds to step S129.

In step S128, the control unit 70 performs a partial provision prohibition process for prohibiting provision of the product from the storage unit 30 having the matching error.
In this partial supply prohibition process, a storage unit supply suspension state is set to suspend supply of products from the storage unit 30 in which the erroneous product has been replenished by the replenishment pattern matching determination process. When this process is completed, the process proceeds to step S129.

In this way, when a replenishing worker replenishing medicines, the replenishing pattern matching judgment process is used to determine whether the medicine has been correctly replenished in the storage unit 30, and if the wrong product has been replenished, the supply of medicine from that storage unit 30 is prohibited. This prevents the wrong medicine from being replenished due to the replenishing worker's assumptions or misunderstandings, and can prevent the wrong medicine from being supplied.

In step S129, the control unit 70 determines whether or not a confirmation operation has been received from the replenisher to confirm that the photographed replenishment product image corresponds to the sample replenishment product image for one storage shelf D.
If the control unit 70 determines that a confirmation operation has been received for one storage level D, it transfers processing to step S130, and if it determines that a confirmation operation has not been received for one storage level D, it waits until a confirmation operation is received.

In step S130, the control unit 70 performs a check data storage process for storing the storage stage D for which the confirmation operation has been accepted.
In this check data storage process, the check data is stored in association with the storage stage D for which the checking operation has been accepted, and the display unit 10 is caused to display a message indicating that the storage stage D for which the checking operation has been accepted has been checked. When this process ends, the process proceeds to step S131.

In step S131, the control unit 70 determines whether or not the check data for all the storage stages D1 to D10 has been stored.
If the control unit 70 determines that check data for all storage stages D1 to D10 has been stored, it transfers the process to step S132, and if it determines that check data for all storage stages D1 to D10 has not been stored, it returns the process to step S129.

In this way, by repeating the processing of steps S129 to S131, the replenisher can visually check the photographed replenishment product images and sample replenishment product images for each storage tier D1 to D10, preventing the replenisher from replenishing the wrong products.

In steps S129 to S131, the replenisher's confirmation operation is configured to check each horizontal storage tier D one by one, but it may also be configured to check each vertical storage lane R one by one for all storage lanes R1 to R4. Furthermore, the replenisher's confirmation operation may be configured to check each product one by one, or to check all products at once.

In step S132, the control unit 70 executes a total inventory information transmission process for calculating and transmitting the inventory of medicines replenished in all storage units 30.
In this total inventory information transmission process, the inventory numbers of medicines replenished in all storage units 30 are calculated, and the calculated inventory numbers and the unique information of the product provision processing device are transmitted to the product provision server 310. When this process is completed, the process proceeds to step S133.

In step S133, the control unit 70 performs a product permission process for permitting provision of the product.
In this product authorization process, the display unit 10 displays that the replenisher has completed the replenishing of medicines, and the provision of the product is authorized. Note that in the product authorization process, the storage unit provision suspension state set in the partial provision prohibition process (step S128) is not released. When this process is completed, the current product replenishing confirmation process is terminated.

In this way, in the product replenishment confirmation process of this embodiment, when a replenisher performs the task of replenishing medicines, a first stage of software check is performed by the replenishment pattern matching judgment process to check whether the medicines have been correctly replenished in the storage unit 30, and a second stage of manual check (double check) is performed by the replenisher checking each storage stage D one by one, thereby preventing the wrong medicine from being replenished in the storage unit 30 and preventing health damage caused by taking the wrong medicine.

(Prevention of health hazards caused by OTC drugs)
Next, a description will be given of details of the process for preventing health damage to OTC drugs by the product provision processing device 100. Fig. 9 is an example of a flowchart showing the process for preventing health damage to OTC drugs by the product provision processing device according to the first embodiment.

As shown in FIG. 9, in step S141, the control unit 70 performs an ingredient information extraction process to extract ingredient information from the medicine included in the registration information of the reserved product.
In this ingredient information extraction process, the ingredient information included in the various medicines stored in the storage unit 81 is referenced, and the ingredient information is extracted from the medicine included in the registration information of the reserved product. When this process is completed, the process proceeds to step S142.

In step S142, the control unit 70 determines whether or not the drug contains any particular ingredient that requires caution when taken, based on the extracted drug ingredient information.
If the control unit 70 determines that the specific ingredient is contained, it proceeds to step S143, and if it determines that the specific ingredient is not contained, it terminates the current process of preventing health damage to the OTC drug.

In step S143, the control unit 70 performs a server check request process.
In this server check request process, the user's unique information, the drug's ingredient information, the unique information of the product provision processing device, etc. are transmitted to the product provision server 310. When this process ends, the process proceeds to step S144.

When the product provision server 310 receives the user's unique information, the ingredient information of the drug to be provided, the unique information of the product provision processing device, etc. from the product provision processing device 100, it refers to the history information of previously provided drugs that is associated with the user's unique information, performs abuse prevention judgment processing and contraindication prevention judgment processing, and transmits each judgment result to the product provision processing device 100 that has the unique information of the product provision processing device that received it.

In the abuse prevention determination process, the history information of the medicines provided during a specified period associated with the user's unique information is referenced, and a determination is made as to whether or not a specified number of medicines containing the ingredient information of the provided medicine have been provided within the specified period. If it is determined that a specified number of medicines containing the ingredient information of the provided medicine have been provided within the specified period, "ingredient abuse information" is sent to the product provision processing device 100, and if it is determined that a specified number of medicines containing the ingredient information of the provided medicine have not been provided within the specified period, "normal dosing information" is sent to the product provision processing device 100.

In the incompatibility prevention judgment process, past ingredient information is extracted from the medicines provided during a specific period associated with the user's unique information, and information on incompatibility combinations of various types of ingredient information that are contraindicated for combined use is referenced to judge whether the ingredient information of the provided medicine and the past ingredient information are incompatibility combinations. If it is determined that there is an incompatibility combination, "information that there is a incompatibility" is transmitted to the product provision processing device 100, and if it is determined that there is no incompatibility combination, "information that there is no incompatibility" is transmitted to the product provision processing device 100.
The system also refers to information on caution combinations of various types of ingredient information that are cautions for combined use, and judges whether the ingredient information of the drug to be provided and the past ingredient information are caution combinations. If it is judged that they are caution combinations, it transmits "contraindication warning information" to the product provision processing device 100, and if it is judged that they are not caution combinations, it transmits "no caution information" to the product provision processing device 100.

Returning to the processing of the product provision processing device 100, in step S144, the control unit 70 judges whether or not to provide a product containing a predetermined number or more of specific ingredients in a predetermined period of time based on the information transmitted from the product provision server 310. Specifically, by receiving "ingredient abuse information" from the product provision server 310, it is judged that a product containing a predetermined number or more of specific ingredients in a predetermined period of time will be provided, and by receiving "normal dosing information" from the product provision server 310, it is judged that a product containing a predetermined number or more of specific ingredients in a predetermined period of time will not be provided.
If the control unit 70 determines that a product containing a predetermined number or more of specific ingredients will be provided during a specified period of time, it transfers processing to step S148, and if it determines that a product containing a predetermined number or more of specific ingredients will not be provided during a specified period of time, it transfers processing to step S145.

In step S145, the control unit 70 determines whether or not to provide a medicine containing ingredients that will be in a forbidden combination during the specific period, based on the information transmitted from the product providing server 310. Specifically, the control unit 70 determines to provide a medicine containing ingredients that will be in a forbidden combination during the specific period by receiving "contraindication information" from the product providing server 310, and determines not to provide a medicine containing ingredients that will be in a forbidden combination during the specific period by receiving "no contraindication information" from the product providing server 310.
If the control unit 70 determines that a medicine containing ingredients that are in a forbidden combination during the specified period will be provided, the control unit 70 transfers processing to step S148, and if the control unit 70 determines that a medicine containing ingredients that are in a forbidden combination during the specified period will not be provided, the control unit 70 transfers processing to step S146.

In step S146, the control unit 70 determines whether or not to provide a medicine containing ingredients that constitute a caution combination during the specific period, based on the information transmitted from the product providing server 310. Specifically, the control unit 70 determines to provide a medicine containing ingredients that constitute a caution combination during the specific period by receiving "contraindication warning information" from the product providing server 310, and determines not to provide a medicine containing ingredients that constitute a caution combination during the specific period by receiving "no warning information" from the product providing server 310.
If the control unit 70 determines that a medicine containing ingredients that constitute a caution combination will be provided during the specified period, it proceeds to step S147; if it determines that a medicine containing ingredients that constitute a caution combination will not be provided during the specified period, it terminates the current process for preventing health damage to OTC medicines.

In step S147, the control unit 70 sets combination warning display data that causes the display unit 10 to display a warning about combining the currently provided drug with ingredients of a previously provided drug. When this process ends, the current OTC drug health damage prevention process ends. Note that even if the combination warning display data is set, the drug will still be provided, as described below.

In addition, when providing a medicine that contains ingredients that are combinations that require caution during a specific period, a message will be displayed urging caution when combining the current medicine with ingredients from medicines provided in the past, alerting users and preventing health damage from occurring.

In step S148, the control unit 70 performs a supply stop process to stop the supply of the medicine when a product containing a specified number or more of specific ingredients is to be provided during a specified period, or when a medicine containing ingredients that are combinations of caution is to be provided during a specified period. In this supply stop process, supply prohibition information that prohibits the supply of the product is set. When this process is completed, the health damage prevention process for this OTC medicine is completed.

In this way, when a product containing a specific ingredient is provided in a specified number or more within a specified period, the provision of the drug is suspended, preventing abuse by users of drugs containing the same active ingredient and preventing the occurrence of health damage. In particular, the abuse prevention determination process determines whether or not a specified number or more of drugs containing ingredient information of the provided drug have been provided within a specified period, so that abuse by users of drugs containing the same active ingredient is more appropriately prevented and health damage can be more firmly prevented without being limited to the same drug or distinguishing between original drugs and generic drugs.

In addition, if the pharmaceutical being provided this time has ingredients that are contraindicated for combined use with pharmaceuticals provided in the past, the provision of the pharmaceutical will be suspended, thereby preventing health damage caused by contraindications for combined use.

(Product provision processing by product provision processing device)
Next, a description will be given of details of the product provision process of the product provision processing device 100. Fig. 10 is an example of a flowchart showing the product provision process of the product provision processing device according to the first embodiment.

As shown in FIG. 10, in step S151, the control unit 70 determines whether or not provision prohibition information has been set.
If the control unit 70 determines that the provision prohibition information has been set, the process proceeds to step S152. If the control unit 70 determines that the provision prohibition information has not been set, the process proceeds to step S153.

In step S152, the control unit 70 performs a medicine error display process to cause the display unit 10 to display a message indicating that provision of the medicine is prohibited.
In this drug error display process, the display unit 10 displays that the drug is prohibited from being provided based on information resulting from the setting of the provision prohibition information (second denial information indicating the pharmacist's denial, ingredient abuse information, and contraindication information). When this process ends, the current product provision process ends.

In step S<b>153 , the control unit 70 performs an elevator outward drive process to move the elevator 40 to a position facing the storage unit 30 .
In this elevator outward drive process, the position of the storage level D of the storage unit 30 in which the medicine to be provided is stored is calculated, and the elevator 40 is moved by the lift drive unit 44 to the calculated position of the storage level D. When this process is completed, the process proceeds to step S154.

In step S154, the control unit 70 performs an internal camera photographing process in which the internal camera 21 photographs the medicine to be provided this time that is stored in the storage unit 30.
In this internal camera photographing process, the internal camera 21 photographs the medicines to be provided this time stored in the storage unit 30 facing the elevator 40, and obtains a provided product image of the medicines to be provided this time. When this process is completed, the process proceeds to step S155.

In step S155, the control unit 70 performs a pattern matching determination process.
In this pattern matching determination process, pattern matching is performed between the acquired provided product image and a sample product image when a correct product is stored in the storage unit 30, and it is determined whether or not an incorrect medicine is stored. When this process is completed, the process proceeds to step S156.

In step S156, the control unit 70 determines whether or not it has been determined by the pattern matching determination process that the wrong medicine has been stored, that is, whether or not a matching error has occurred.
If the control unit 70 determines that a matching error has occurred, the process proceeds to step S157. If the control unit 70 determines that a matching error has not occurred, the process proceeds to step S159.

In step S157, the control unit 70 performs a provision error display process to display on the display unit 10 that the medicine to be provided has been stored incorrectly and the medicine cannot be provided. When this process ends, the process proceeds to step S158.

In step S158, the control unit 70 performs a partial provision prohibition process for prohibiting provision of the product from the storage unit 30 having the matching error.
In this partial provision prohibition process, a storage unit provision stop state is set in which provision of products from the storage unit 30 in which the incorrect medicine is stored is stopped by the pattern matching determination process. This stops future provision of products from the storage unit 30 in which the incorrect medicine is stored. Then, the elevator 40 is returned to a position facing the product take-out port 12 by the lift drive unit 44. When this process is completed, the current product provision process is terminated.

In this way, even when a medicine is provided, a pattern matching judgment process is used to check immediately beforehand whether the wrong medicine has been stored in the storage unit 30, preventing the wrong product from being provided. Also, when medicine is refilled, a double check is performed to check whether the wrong medicine has been refilled in the storage unit 30. Even if the wrong medicine has been refilled at the back of the storage unit 30, it is possible to discover that the wrong medicine has been stored in the storage unit 30 immediately before providing the medicine, and the correct medicine can be provided more accurately.

Furthermore, even if the pattern matching judgment process determines that the wrong medicine is stored in the storage unit 30, the supply of medicines from the storage unit 30 in which the wrong medicine is stored is stopped without stopping the supply of all products by the product provision processing device 100, so that the supply of products from the storage unit 30 that has been correctly refilled with medicines can continue, and a decrease in the operating rate of product supply by the product provision processing device 100 can be suppressed.

This is because the internal camera 21 photographs the medicines to be provided that are stored in the storage section 30. If the internal camera 21 photographs the medicines placed on the tray 41 and performs pattern matching between the image of the medicines placed on the tray 41 and the sample product image, in the event of a matching error, the elevator 40 would have to be stopped from operating or the product removal port 12 would be closed, and the product provision processing device 100 would have to stop providing all products.

In the first product supply processing device 100A, in step S159, the control unit 70 performs a purchase price payment confirmation process.
In this purchase price payment confirmation process, the purchase price of the medicine to be provided is calculated, the payment from the user is confirmed via the monetary information input/output unit 60, and if the payment from the user is sufficient to cover the purchase price, the process proceeds to step S160 to provide the medicine to the user. If the payment from the user exceeds the purchase price, the change is calculated and the calculated change is discharged to the change outlet 18.

In addition, the second product provision processing device 100B installed in a retail store such as a convenience store does not have a payment unit, so the above-mentioned purchase price payment confirmation process is not performed and processing proceeds to step S160. As described above, accounting for medicines provided by the second product provision processing device 100B is performed at the retail store where the second product provision processing device 100B is installed.

In step S<b>160 , the control unit 70 performs a conveyor driving process for driving the conveyor 31 .
In this conveyor driving process, the belt driving unit 34 provided on the conveyor 31 of the storage unit 30 in which the medicines to be provided are stored is driven to transport the medicines to be provided stored in the storage unit 30 to the elevator 40. By this conveyor driving process, the medicines to be provided stored in the storage unit 30 are placed on the tray 41 of the elevator 40. When this process is completed, the process proceeds to step S161.

In step S161, the control unit 70 performs an elevator return drive process in which the lift drive unit 44 moves the elevator 40 to a position opposite the product outlet 12. When this process ends, the process proceeds to step S162.

In step S162, the control unit 70 performs a product outlet opening process to open the opening/closing door 13 using the opening/closing drive unit 91. This product outlet opening process allows the user to receive medicines provided by the product provision processing device 100 from the product outlet 12. When this process is completed, the process proceeds to step S163.

In step S163, the control unit 70 performs a provision display process to cause the display unit 10 to display that provision of the medicine has been completed.
In this provision display process, if the concomitant use warning display data is set, a message is displayed on the display unit 10 stating that the drug provided this time should not be used in combination with ingredients of drugs provided in the past, when the provision of the drug is completed, and if the concomitant use warning display data is not set, a message is displayed on the display unit 10 indicating that the provision of the drug has been completed normally. When this process is completed, the current product provision process is terminated.

In this embodiment, the product provision server 310 is configured to perform the abuse prevention determination process and the contraindication prevention determination process. However, the product provision processing device 100 may also be configured to obtain information on previously provided medicines associated with the user's unique information from the product provision server 310, and the product provision processing device 100 may be configured to perform the abuse prevention determination process and the contraindication prevention determination process.

[Display screen of user terminal device]
A description will now be given of an example of a display screen displayed on the terminal display unit 204 of the above-mentioned user terminal device 200. Fig. 11 shows an example of a display screen displayed on the terminal display unit of the user terminal device according to the first embodiment.

Figure 11 (a) is an example of a product selection display screen that is displayed on the terminal display unit 204 of the user terminal device 200 when the user terminal device 200 selects a medicine as a reserved product (e.g., step S2).

As shown in FIG. 11(a), the product selection display screen displays at least a first button image for the user to select a purchasing route for directly selecting a medicine and purchasing the medicine, and a second button image for the user to select a purchasing route for selecting a symptom and purchasing the medicine. The user decides on the medicine purchasing route by touching the first button image or the second button image, narrows down the medicines based on various selection information, and decides on the narrowed down medicines as the reserved product.

Figure 11 (b) is an example of a reserved item confirmation display screen that is displayed on the terminal display unit 204 of the user terminal device 200 when the user decides on the reserved item (step S2, etc.).

As shown in FIG. 11(b), the reserved item confirmation display screen displays information about the drug to be determined as the reserved item, a "Yes" button image for determining the reserved item, and a "No" button image for canceling the reserved item. If the drug to be determined as the reserved item is a specific drug (e.g., a Category 1 drug), an interview transition image is displayed to notify the user that a medical interview with a pharmacist will be conducted (e.g., text stating "Category 1 drugs require the approval of a pharmacist, and a QA with the pharmacist will be conducted"). The user determines the reserved item by touching the "Yes" button image, and if the drug to be determined as the reserved item is a specific drug, a medical interview with a pharmacist will be conducted.

Figure 11 (c) is an example of a medical interview display screen that is displayed on the terminal display unit 204 of the user terminal device 200 when the pharmacist is conducting a medical interview with the user (e.g., step S5).

As shown in FIG. 11(c), the interview display screen displays the contents of the pharmacist's conversation and the user's conversation in a text-based manner such as chat. Note that in this embodiment, the conversation is configured to be conducted in a text-based manner such as chat, but the conversation may be conducted only by voice or by video call. The pharmacist will approve a specific medicine through the pharmacist terminal device 340 based on the interview with the user.

Figure 11 (d) shows an example of a reservation result list display screen that is displayed on the terminal display unit 204 of the user terminal device 200 by the reservation result list display process (step S7) after a specific medicine has been approved by a pharmacist and registration information of the reserved product and location information of the product provision processing device are received from the product provision server 310.

As shown in FIG. 11(d), the reservation result list display screen displays an explanatory image showing the registration information of the reserved item, and also displays a location information image (e.g., a star mark) of the product provision processing device 100 at which the reserved item can be received, together with a map image of the surrounding area, based on the current location information of the user terminal device 200. The user can look at the location information image and move to the location of the product provision processing device 100 at which the reserved item can be received.

In addition to the location information image of the product provision processing device 100 that can receive the reserved product, the number of reserved products stored in the product provision processing device 100 may also be displayed. When configured in this manner, the product provision server 310 transmits to the user terminal device 200 information on the number of products in stock stored in the product provision processing device 100 in addition to the location information of the product provision processing device 100.

[Display screen of product provision processing device]
An example of a display screen displayed on the display unit 10 of the above-mentioned product provision processing apparatus 100 will be described.

(Display screen when picking up reservation)
First, a display screen displayed on the display unit 10 when a reserved product is received in the product provision processing device 100 will be described with reference to Fig. 12 and Fig. 13. Fig. 12 and Fig. 13 are examples of display screens displayed on the display unit 10 when a reserved product is received in the product provision processing device 100 according to the first embodiment.

Figure 12 (a) is an example of a reception display screen displayed on the display unit 10 of the product provision processing device 100 when the reception waiting process for receiving operations from the user is being performed (steps S11 and S102).

As shown in FIG. 12(a), the reception display screen displays a purchase operation image for receiving a product purchase operation from the user, and a receiving operation image for receiving a reserved product from the user. The user performs a product purchase operation by touching the purchase operation image, and performs a receiving operation for a reserved product by touching the receiving operation image.

Figure 12 (b) is an example of an authentication code display screen that is displayed on the display unit 10 of the product provision processing device 100 when a user performs an operation to receive a reserved product (steps S12 and S103).

As shown in FIG. 12(b), the authentication code display screen displays authentication code information such as a QR code. The user reads the authentication code information displayed on the display unit 10 of the product provision processing device 100 using the user terminal device 200, and accesses the product provision server 310.

Figure 12 (c) is an example of an approval display screen that is displayed on the display unit 10 of the product provision processing device 100 when the user terminal device 200 accesses the product provision server 310 based on the authentication code information and the pharmacist is approving the reserved product (step S55).

As shown in FIG. 12(c), the approval display screen shows that the pharmacist is approving the reserved item and is waiting.

Figure 12 (d) is an example of a provided product confirmation display screen that is displayed on the display unit 10 of the product provision processing device 100 when the pharmacist completes the approval process for the reserved product and receives second approval information indicating the pharmacist's approval as second approval result information from the product provision server 310 (steps S18 and S117).

As shown in FIG. 12(d), the provided product confirmation display screen displays information about the medicine to be provided, a "Yes" button image for confirming the medicine to be provided, and a "No" button image for canceling the medicine to be provided. The user confirms the medicine to be provided by touching the "Yes" button image, and the product provision processing device 100 performs product provision processing (steps S19 and S118) to provide the medicine.

Figure 13 (a) shows an example of a normal provision completion display screen that is displayed on the display unit 10 of the product provision processing device 100 by the provision display process (step S163) when a medicine is provided when the concomitant use warning display data is not set.

As shown in FIG. 13(a), the normal delivery completion display screen displays a delivery completion image (e.g., the text "Please collect the product from the product outlet") to inform the user that the medicine has been delivered.

Figure 13 (b) shows an example of a warning provision completion display screen that is displayed on the display unit 10 of the product provision processing device 100 by the provision display process (step S163) when the concomitant use warning display data is set and the medicine is provided.

As shown in FIG. 13(b), the warning provision completion display screen displays, in addition to a provision completion image, a combination use warning image informing the user that the currently provided drug should not be used in combination with ingredients of previously provided drugs (for example, the text "Please be careful not to use ingredient A of the currently provided drug ABC in combination with ingredient B of drug Z").

Figure 13 (c) is an example of a provision error display screen that is displayed on the display unit 10 of the product provision processing device 100 by the provision error display process (step S157) when a medicine is not provided due to a matching error when providing the medicine.

As shown in FIG. 13(c), the supply error display screen displays an error notification image notifying the user of a matching error (e.g., the text "Corresponding drug not found") along with a supply prohibition image notifying the user that the drug cannot be provided (e.g., the text "This drug cannot be provided") on the supply error display screen. In addition, the supply error display screen displays a first corresponding image corresponding to the matching error (e.g., the text "We ask that you change the vending machine from which you make your purchase").

Figure 13 (d) is an example of an abuse prevention display screen that is displayed on the display unit 10 of the product provision processing device 100 by the drug error display process (step S152) when a drug is not provided due to abuse prevention when providing the drug.

As shown in FIG. 13(d), the abuse prevention display screen displays an abuse prevention notification image (e.g., the text "To prevent abuse of specific ingredients") that notifies users of abuse prevention together with the prohibited provision image. In addition, the abuse prevention display screen displays a second corresponding image (e.g., the text "Please consult with a pharmacist at a pharmacy before purchasing") that corresponds to abuse prevention.

Figure 13 (e) is an example of a contraindication for combination display screen that is displayed on the display unit 10 of the product provision processing device 100 by the drug error display process (step S152) when a drug is not provided due to a contraindication for combination when providing the drug.

As shown in FIG. 13(e), the contraindication display screen displays a contraindication notification image (e.g., text "Component A of drug ABC and component C of drug X are contraindicated for use together") that notifies users of the contraindication, along with the prohibited image. In addition, the contraindication display screen displays a second corresponding image (e.g., text "Please consult with a pharmacist at a pharmacy before purchasing") that corresponds to the contraindication.

(Display screen during refilling)
Next, a display screen displayed on the display unit 10 when a refilling operation is performed in the product processing device 100 will be described with reference to Fig. 14. Fig. 14 is an example of a display screen displayed on the display unit 10 when a refilling operation is performed in the product processing device 100 according to the first embodiment.

Figure 14 (a) is an example of a judgment result display screen that is displayed on the display unit 10 of the product provision processing device 100 when the replenishing work of the replenishing person is completed and the replenishing pattern matching display process is performed (step S126).

As shown in FIG. 14(a), the judgment result display screen displays a judgment image of the judgment result from the pattern matching judgment process at the time of refilling (for example, the text "Pattern matching: normal"), and also displays the entire photographed replenishment product image and the entire sample replenishment product image for comparison. The replenisher can understand the judgment result from the pattern matching judgment process at the time of refilling from the judgment result display screen.

Furthermore, on the judgment result display screen, a confirmation operation instruction image (e.g., text "Compare the sample image with the photographed image and check (touch) each tier of the photographed image") is displayed to encourage the replenisher to confirm that the photographed replenishment product images of each storage tier D correspond to the sample replenishment product images. The replenisher will confirm that the storage tiers D of the photographed replenishment product images correspond to the storage tiers D of the sample replenishment product images one by one, and touch the storage tiers D of the photographed replenishment product images that have been confirmed.

Figure 14 (b) is an example of a check display screen that is displayed on the display unit 10 of the product provision processing device 100 when the topmost storage level D1 of the photographed replenishment product images is checked by the replenisher (step S130).

As shown in FIG. 14(b), on the check display screen, when the storage level D1 of the photographed replenishment product image is touched by the replenisher, the background color of the storage level D1 of the photographed replenishment product image is changed and a check mark is displayed to the right of the storage level D1 of the photographed replenishment product image, indicating that a confirmation operation has been received confirming that the storage level D1 of the photographed replenishment product image corresponds to the storage level D1 of the sample replenishment product image.

Figure 14 (c) is an example of a checked display screen that is displayed on the display unit 10 of the product provision processing device 100 when all storage shelves D of the photographed replenishment product images have been checked by the replenisher (step S130).

As shown in FIG. 14(c), on the checked display screen, the background color of all storage levels D of the photographed replenishment product images is changed, and a check mark is displayed to the right of all storage levels D of the photographed replenishment product images. In addition, on the checked display screen, a check completion notification image (e.g., the text "Replenishment check completed") is displayed to notify that checking of all storage levels D of the photographed replenishment product images has been completed.

Figure 14 (d) is an example of a restocking work completion display screen that is displayed on the display unit 10 of the product provision processing device 100 when all storage shelves D of the photographed restocking product images have been checked and the restocker's restocking work of medicines is completed (step S133).

As shown in FIG. 14(d), the refill work completion display screen displays a refill work completion notification image (e.g., the text "Thank you for your hard work on the refill work") to inform the refiller that the refill work of the medicines is completed.

As described above, in this embodiment, when a user selects a specific product (specific medicine) as a reserved product from the user terminal device 200, the user terminal device 200 conducts an interview with a person in charge (pharmacist) regarding the specific product, and the person in charge approves the specific product, and then the user terminal device 200 displays location information of a product provision processing device 100 that can provide the reserved product.
As a result, interviews with the person in charge can be conducted via the user terminal device 200, making it easier to protect the user's privacy, and the user can know where to go to receive the reserved product from the product provision processing device 100, thereby improving the convenience of product provision.

Furthermore, as the product provision processing device 100 capable of providing the reserved product, a product provision processing device is extracted that has an inventory of the product corresponding to the reserved product and the storage unit 30 that stores the product corresponding to the reserved product is in a storage unit provision permission state, so that the chances that the reserved product cannot be received when receiving the reserved product due to the product provision processing device 100 being sold out or not being provided can be reduced.

In this embodiment, when the user determines a reserved product from the user terminal device 200, the product provision processing device 100 that will receive the reserved product is not determined. When the user receives the reserved product from the product provision processing device 100, the user terminal device 200 reads the authentication code information displayed on the product provision processing device 100 and transmits the registration information and the like of the reserved product to the product provision server 310. The product provision server 310 transfers the registration information and the like of the reserved product to the product provision processing device 100, and the product provision processing device 100 permits the provision of the reserved product based on the registration information and the like of the reserved product.
Therefore, when a user determines a reserved product from the user terminal device 200, the reserved product can be received from any product provision processing device 100 that can provide the reserved product, improving the convenience of product provision. Furthermore, since the reserved product is not determined in advance in the product provision processing device 100, the burden of processing to secure the reserved product (control of sold-out due to subtraction of the reserved product, cancellation processing of the reserved product due to the reservation deadline, inventory management processing, etc.) can be reduced, and the loss of opportunity to provide the reserved product to a third party due to sold-out due to securing the reserved product can be suppressed, thereby maintaining the operation of product provision.

In addition, in this embodiment, when a user selects a specific product (specific medicine) as a reserved product from the user terminal device 200, the person in charge performs a first approval process (first pharmacist approval process in step S53), and when the user receives the reserved product from the product provision processing device 100, the person in charge performs a second approval process (second pharmacist approval process in step S55).
This makes it possible to prevent a user who receives a reserved product from the product provision processing device 100 from masquerading as a user who has decided to reserve the product from the user terminal device 200 and receiving the reserved product.

Furthermore, a portion of the incentive is paid to the person in charge when the person in charge performs the first approval process (first incentive payment process in step S36), and the remaining amount of the incentive is paid to the person in charge when the reserved product is provided by the product provision processing device 100 after the person in charge performs the second approval process (second incentive payment process in step S47).
Therefore, even if a user decides on a reserved item but cancels the reserved item and the item is not actually provided by the product provision processing device 100, a part of the incentive is paid when the first approval process is performed, so that the approval work of the person in charge is not entirely wasted due to the cancellation of the reserved item, and the person in charge can be made to proactively perform the approval work, thereby improving the operating rate of the product provision system 1.

Furthermore, the first approval process by the responsible person is performed by the responsible person who first transmits the medical interview application information to the pharmacist server 320 (so-called first come, first served).
This reduces the waiting time for the person in charge to participate in the user interview, and further improves the operating rate of the product provision system 1.

Furthermore, the unit price of the incentive paid to the person in charge is set based on the number of accesses of the person in charge to server 300, with the unit price of the incentive being set higher during times when the number of accesses of the person in charge is low, such as late at night or on holidays, and set lower during times when the number of accesses of the person in charge is high, such as during the day or on weekdays (step S36).
This makes it possible to automatically control the setting of incentive prices during times of low access, allowing the approval work by the person in charge to be carried out stably during late night hours, holidays, etc., and further improving the operating rate of the product provision system 1.

In addition, in this embodiment, when a replenisher performs the task of replenishing medicines, pattern matching is performed between the photographed replenishment product image and the sample replenishment product image (step S123) to determine whether the medicine has been correctly replenished in the storage unit 30, and if the wrong product has been replenished, the provision of medicines from that storage unit 30 is prohibited (steps S127, S128).
This prevents the wrong medicine from being refilled due to the refiller's assumptions or misunderstandings, and prevents the wrong medicine from being provided, thereby preventing health hazards caused by taking the wrong medicine.

Furthermore, when pattern matching is performed between the photographed replenishment product images and the sample replenishment product images, the photographed replenishment product images and the sample replenishment product images are displayed on the display unit 10 of the product provision processing device 100 in comparison with each other along with the determination result of the pattern matching between the photographed replenishment product images and the sample replenishment product images (step S126, display screen of FIG. 14). In addition, the replenisher is made to perform a confirmation operation to confirm that each storage level D of the photographed replenishment product images corresponds to each storage level D of the sample replenishment product images (steps S129 to S131, display screen of FIG. 14).
Therefore, a first stage check by software is performed by pattern matching to check whether the medicines have been properly refilled into the storage unit 30, and a second stage check (double check) is performed manually by a refiller checking each storage stage D one by one, so that it is possible to prevent the wrong medicine from being refilled into the storage unit 30 and the wrong medicine from being provided. This makes it possible to prevent health hazards caused by taking the wrong medicine.

In addition, in this embodiment, when the product provision processing device 100 provides a medicine, it performs pattern matching between the provided product image and the sample product image (step S155) to determine whether the correct medicine is stored in the storage unit 30, and if the incorrect medicine is stored, it prohibits the provision of the medicine from that storage unit 30 (steps S156, S158).
Therefore, when providing a medicine, it is possible to check immediately beforehand whether the wrong medicine has been stored in the storage unit 30, and to prevent the wrong medicine from being provided. This makes it possible to prevent health hazards caused by taking the wrong medicine. Also, when a medicine is refilled, a double check is performed to check whether the wrong medicine has been refilled in the storage unit 30. Even if the wrong medicine has been refilled deep inside the storage unit 30, it is possible to discover that the wrong medicine has been stored in the storage unit 30 immediately before providing the medicine, and it is possible to provide the correct medicine more accurately.

Furthermore, in this embodiment, even when a replenishing worker performs the task of replenishing medicines, or when pattern matching is performed when the product provision processing device 100 provides medicines and it is determined that an incorrect medicine is stored in the storage unit 30, the provision of medicines from the storage unit 30 in which the incorrect medicine is stored is stopped without stopping the provision of all products by the product provision processing device 100.
Therefore, it is possible to continue providing products from the storage unit 30 in which medicines are correctly stored, and a decrease in the operating rate for providing products can be suppressed.

In addition, in this embodiment, when the product provision processing device 100 provides a pharmaceutical product, it determines whether or not to provide a product containing a predetermined number or more of specific ingredients for a predetermined period of time (step S144), and if it determines that a product containing a predetermined number or more of specific ingredients will be provided for a predetermined period of time, it stops providing the pharmaceutical product (step S148).
Therefore, if a prescribed number or more of drugs having the same active ingredient are to be provided within a prescribed period, the provision of the drug will be suspended, preventing abuse by users of drugs having the same active ingredient and preventing health damage. In particular, without being limited to the same drug or distinguishing between original and generic drugs, abuse by users of drugs having the same active ingredient can be more appropriately prevented and health damage can be prevented.

In addition, in this embodiment, when the product provision processing device 100 provides a medicine, it determines whether or not to provide a medicine containing ingredients that would be in a forbidden combination during a specific period (step S145), and if it determines that a medicine containing ingredients that would be in a forbidden combination during a specific period will be provided, it stops providing the medicine (step S148).
For this reason, if the pharmaceutical product being provided this time has ingredients that are contraindicated for combined use with pharmaceutical products provided in the past, the provision of the pharmaceutical product will be suspended, thereby preventing health damage caused by such contraindications.

In addition, in this embodiment, when the product provision processing device 100 provides a medicine, it determines whether or not to provide a medicine containing ingredients that are a cautionary combination during a specific period (step S146), and if it determines that a medicine containing ingredients that are a cautionary combination during a specific period will be provided, it issues a warning to be careful not to use the medicine currently being provided in combination with ingredients of medicines provided in the past (steps S147, S152).
For this reason, a warning will be issued urging people to be careful not to use the current medicine in combination with ingredients from medicines previously provided, which will help prevent health damage caused by the current medicine.

In other words, in this embodiment, when a user selects a specific medicine as a reserved item, a "first check" is performed by a pharmacist to determine whether the medicine selected by the user is the appropriate medicine, and when a replenishing person refills the medicine, a "second check" is performed by pattern matching between the photographed replenishing product image and the sample replenishing product image to determine whether it is the correct medicine, and a "third check" is performed by the replenishing person's confirmation operation, and when a medicine is provided, a "fourth check" is performed by pattern matching between the provided product image and the sample product image to determine whether it is the correct medicine. This can more reliably prevent health damage caused by taking the wrong medicine for the user's condition.

Furthermore, when providing medicines, a "fifth check" will be carried out to prevent abuse by users of medicines that contain the same active ingredients, a "sixth check" to see if the medicine is contraindicated for use in combination with ingredients of medicines previously provided, and a "seventh check" to see if the medicine requires caution when used in combination with ingredients of medicines previously provided. This will make it possible to more firmly prevent health damage caused by taking medicines.

In addition, in embodiment 1, when a user receives a reserved product (medicine) from the product provision processing device 100, the product provision processing device 100 displays authentication code information, and the user terminal device 200 reads the authentication code information, so that the medicine is provided from the product provision processing device 100.
However, when a user receives a reserved product (medicine) from the product provision processing device 100, the user terminal device 200 may display code information, and the product provision processing device 100 may read the code information so that the medicine is provided by the product provision processing device 100.

[Embodiment 2]
The product provision system 1 and product provision processing device 100 of embodiment 2 are configured so that, when a user receives a reserved product (medicine) from the product provision processing device 100, the user terminal device 200 displays approval code information, and the product provision processing device 100 reads the approval code information, thereby providing the medicine from the product provision processing device 100.
The product provision system 1 and the product provision processing device 100 according to the second embodiment will be described below.

The external configuration of the product provision processing device 100 and the internal configuration of the product provision system 1 according to the second embodiment are similar to the external configuration of the product provision processing device 100 according to the first embodiment (see Figures 1 to 3) and the internal configuration of the product provision system 1 (see Figure 5). The product provision system 1 and the product provision processing device 100 according to the second embodiment differ in part in the processing content compared to the product provision system 1 and the product provision processing device 100 according to the first embodiment. In describing the processing of the second embodiment, the same symbols and numbers are used for processing similar to the processing of the first embodiment, and detailed description of the processing will be omitted.

[Sequence diagram of product provision system according to the second embodiment]
FIG. 15 is an example of a sequence diagram showing a processing transition when a reservation is accepted by the product provision system of embodiment 2, and FIG. 16 is an example of a sequence diagram showing a processing transition when a reservation is received by the product provision system of embodiment 2.

(Sequence at the time of accepting a reservation in the second embodiment)
As shown in FIG. 15, when the reserved product registration process (see step S38) is completed, the product providing server 310 performs an approval code information transmission process (step S201).
In this authorization code information transmission process, authorization code information and the like are transmitted to the user terminal device 200. This "authentication code information" includes reservation connection information (URL) for connecting to the product providing server 310, user's unique information, registration information for the reserved product (reserved medicine, number of reserved items, reservation completion time, unique information of the pharmacist who interviewed the patient), and the like.

When the user terminal device 200 receives the approval code information and the like from the product providing server 310, the user terminal device 200 performs an approval code acquisition process (step S202).
In this authorization code acquisition process, the received authorization code information and the like are stored in the terminal storage unit 202 .

(Sequence for receiving reservation in the second embodiment)
As shown in FIG. 16, the product supply processing device 100 performs a reception waiting process for receiving an operation from a user or the like (step S203).
In this reception waiting process, the type of operation from the user is identified, and if the user performs an operation to receive the reserved item, the process proceeds to an approval code information reading process (step S205).

The user terminal device 200 reads out the authorization code information etc. stored in the terminal storage unit 202, and performs an authorization code information display process to display the authorization code information on the terminal display unit 204 (step S204).

When the user performs an operation to receive the reserved product, the product supply processing device 100 performs an approval code information reading process (step S205).
In the authorization code information reading process, the authorization code information displayed on the terminal display unit 204 of the user terminal device 200 is read, the read authorization code information is analyzed, and the analyzed authorization code analysis information (reservation connection information, user-specific information, registration information for the reserved item, etc.) is obtained.

After the user photographing process in step S16, the product supply processing device 100 performs a supply application process (step S206).
In this supply application process, the registration information of the reserved product, the supply application information, the user image, the user's unique information, and the like are transmitted to the product supply server 310 .

In this way, the product provision system 1 and product provision processing device 100 according to the second embodiment also allow a user to determine a reserved product (medicine) using the user terminal device 200, and receive the reserved product (medicine) determined by the user from the product provision processing device 100. Thus, the second embodiment can also achieve the same actions and effects as the first embodiment.

[Other variations]

In the first and second embodiments, the product provision processing device 100 is configured to provide medicines as products, but it may also provide products such as alcohol, tobacco, etc. When providing products such as alcohol, tobacco, etc., the pharmacist who would be the sales manager when the product is medicine will take over.

In addition, in the first and second embodiments, the product providing and processing device 100 is not equipped with a refrigerator, but it may be configured to be equipped with a refrigerator so that the inside of the product providing and processing device 100 can be adjusted to an appropriate temperature.

In embodiments 1 and 2, when the first product provision processing device 100A is used, payment of the purchase price of the product is made through the financial information input/output unit 60 provided in the first product provision processing device 100A, and when the second product provision processing device 100B is used, the accounting process is performed at the retail store where the second product provision processing device 100B is installed.
However, the system may be configured so that online payment is made in advance at the user terminal device 200 before the reserved product is received from the product supply processing device 100 .

In embodiments 1 and 2, when the product provision processing device 100 provides a medicine, it photographs the medicine to be provided and performs pattern matching between the photographed image of the provided product and a sample product image. If an incorrect medicine is stored, the provision of the medicine from that storage unit 30 is prohibited (steps S155, S156, S158, etc.).
However, the product provision processing device 100 may be configured to photograph the next medicine to be provided after providing the medicine, perform pattern matching between the photographed provided product image and the sample product image, and if the wrong medicine is stored, prohibit the provision of medicine from that storage unit 30. In other words, pattern matching may be performed when the device is in operation and capable of providing products other than when a replenishing person is performing the replenishing work of replenishing products in the storage unit 30.

In the first and second embodiments, when the user decides on a reserved item from the user terminal device 200, the pharmacist's first approval (first pharmacist approval process in step S53) is performed, and when the user receives the reserved item from the product provision processing device 100, the pharmacist's second approval (second pharmacist approval process in step S55) is performed. However, when the user receives the reserved item from the product provision processing device 100, the pharmacist's second approval does not have to be performed.

In the first and second embodiments, when the medicine determined as the reserved item is a regular medicine (e.g., a Class 2 or Class 3 medicine), the regular medicine is provided without the need for approval from a pharmacist.
However, even if the medicine determined as the reserved item is a regular medicine, a pharmacist may perform a simple check and the regular medicine may be provided subject to the pharmacist's approval.

In the first and second embodiments, the second product provision processing device 100B has the storage unit 30 for storing products, and is configured to be installed in a retail store such as a convenience store.
However, the second product provision processing device 100B may be configured not to have a storage unit 30 for storing products, but to stock products within the store, and to perform each process (confirmation of reserved products, authentication of pharmacists, etc.) with the user terminal device 200 and the server 300 without performing product provision processing. In other words, the second product provision processing device 100B may be replaced with a POS terminal (self-register, semi-self-register) installed in front of the cash register of a store such as a convenience store.

It will be clear to those skilled in the art that the above-mentioned embodiments, including modifications, can be applied to each other's technologies.

The above description is intended to be illustrative and not limiting. Thus, it will be apparent to one skilled in the art that modifications may be made to the embodiments of the invention without departing from the scope of the claims.

The terms used in this specification and the claims should be construed as open-ended terms. For example, the term "including" should be construed as "not limited to what is described as including." The term "comprises" should be construed as "not limited to what is described as comprising." The term "having" should be construed as "not limited to what is described as having."

1 Product provision system 30 Storage unit 100 Product provision processing device 100A First product provision processing device 100B Second product provision processing device 200 User terminal device 300 Server 310 Product provision server 320 Pharmacist server 330 Database storage unit 340 Pharmacist terminal device R1 to R4 Storage lanes D1 to D10 Storage stages

Claims (5)

A product provision processing device having a storage unit for storing products, and providing the product from the storage unit in which the selected product is stored when a product is selected by a user operation,
an authentication means for determining whether or not the product selected by the user is an approved product approved by a person in charge of providing the product;
a product providing means for providing a product from the storage unit on condition that the product is determined to be an approved product by the authentication means;
a wrong product determination means for determining whether the product to be provided is a correct product stored in the storage unit or a wrong product;
a product supply stopping means for stopping supply of the product from the storage unit ;
An internal camera that photographs the products stored in the storage unit;
an image display unit for displaying an image ;
The incorrect product determination means
After a replenishment operation of replenishing products in the storage section is performed by a replenisher, an image of the storage section is photographed by the internal camera, and a first pattern matching is performed between the photographed replenishment product image and a sample replenishment product image when a correct product is stored, thereby determining whether or not a wrong product is stored;
The image display unit includes:
Displaying the photographed replenishment product image and the sample replenishment product image in addition to the determination result by the first pattern matching,
The product provision stopping means includes:
When the erroneous product determination means determines that the product is an erroneous product, the product provision processing device stops provision of the product from the storage unit in which the erroneous product is stored. The incorrect product determination means
The product provision processing device according to claim 1, characterized in that, when the device is in operation and capable of providing products, the internal camera photographs the product to be provided stored in the storage unit, and a second pattern matching is performed between the photographed image of the product to be provided and a sample image of a correct product, thereby determining whether the product to be provided is an incorrect product. A confirmation operation receiving unit is provided for receiving a confirmation operation by a replenisher that confirms that the photographed replenishment product image corresponds to the sample replenishment product image,
The product provision stopping means includes:
The product supply processing apparatus according to claim 1 , wherein, when the confirmation operation receiving unit receives the confirmation operation, it is determined that the replenisher has completed the replenishment work and the supply of the product is permitted. An external camera that captures a user;
a user identification means for identifying a user based on an image of the user captured by the external camera;
an ingredient information extraction means for extracting ingredient information about the selected drug when the product selected by the user is a drug;
and an abuse prevention determination means for determining whether or not a predetermined number of medicines including the first ingredient information extracted by the ingredient information extraction means have been provided within a predetermined period of time based on history information of previously provided medicines associated with the user identified by the user identification means,
The product provision stopping means includes:
The product provision processing device according to any one of claims 1 to 3, characterized in that when the abuse prevention determination means determines that a predetermined number or more of medicines containing specific ingredient information have been provided within a predetermined period of time , the provision of the product is stopped. and a contraindication prevention determination means for determining whether a drug containing a first contraindicated ingredient or a second contraindicated ingredient associated with the second ingredient information extracted by the ingredient information extraction means has been provided during a specific period based on history information of previously provided drugs associated with the user identified by the user identification means,
The image display unit includes:
When the incompatibility prevention determination means determines that a medicine containing a first incompatibility ingredient or a second incompatibility ingredient has been provided during a specific period, a warning is displayed;
The product provision stopping means includes:
The product provision processing device according to claim 4 , wherein when the incompatibility prevention determination means determines that a medicine containing a first incompatibility ingredient has been provided during a specific period, provision of the product is stopped.